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ABSTRACT 
 
Virus cell entry represents one of the earliest opportunities for a host to respond to 
infection. Understanding the processes of pathogen detection and restriction employed by 
the host, as well as strategies utilized by the virus itself to evade such processes, is critical 
in developing therapeutics to counter pathogenesis.   Adenovirus (Ad) infections are self-
limiting in healthy populations, but can be devastating to individuals with compromised 
immune systems. Currently, no specific antiviral treatments exist to combat Ad infections 
in susceptible populations. However, because Ad infections are not severe in healthy 
individuals, employing replication-defective Ads as vaccine vectors is generally regarded 
as safe, and as such are undergoing thorough investigation. The effects of Ads on human 
health, both from infection and as a vaccine vector, are substantial; however there are still 
informational gaps when describing the virus’ interactions within host cells to produce an 
infection. Furthermore, viruses manipulate specific pathways to ensure they productively 
replicate and produce progeny virions, making them ideal tools to probe such complex 
host pathways. 
Our lab uses Ad to investigate both mechanisms of host-mediated restriction of 
virus and the pathogen’s methods of evading detection. Understanding the contributions 
of distinct mechanisms employed by Ad to evade host responses and efficiently enter 
cells will enhance the efficacy of future Ad vaccine vectors and identify novel targets for 
antiviral drug developments. Previous studies in our lab show that Ad-induced membrane 
 x 
 
rupture stimulates a host cell response characterized by the recruitment of autophagy 
machinery to sites of damage. Other observations suggest that wild-type Ad5 virions 
evade sequestration by autophagy via the recruitment and engagement of microtubule 
motor proteins. Current studies suggest that multiple viral proteins making up the viral 
capsid function to aid in motor protein recruitment and viral transport throughout the cell, 
but the specific details of these molecular interactions have not been entirely discerned. 
This study examines the mechanisms of autophagy induction by the host during Ad entry, 
and assesses the influences of capsid proteins of virion engagement with microtubules to 
facilitate endosomal egress and translocation to the nucleus. 
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CHAPTER I 
 
INTRODUCTION 
 
Virus-host interactions 
 To survive and proliferate, intracellular pathogens, such as viruses, must evade 
and subvert numerous host cell defenses and establish an infection. To do this, viruses 
overcome passive barriers, such as crossing the cell membrane or trafficking to sites of 
replication, either through direct action or by exploiting host machinery. At the same 
time, once the cell is alerted to the pathogen, the host employs active defenses to curtail 
infection, posing a major barrier to pathogenesis. These defenses include innate 
responses, which attempt to degrade incoming viruses, and adaptive responses to recruit 
immune cells, limit the infection from spreading, and suppress recurring infections. 
Different viruses have evolved various means to overcome both passive and active 
barriers, either through use of viral capsid proteins or with the generation of proteins de 
novo during replication. The ability of the virus to subvert these processes is essential for 
pathogenesis. Many of these active defense mechanisms are typically general cell 
processes utilized in times of stress, and as such have been characterized and studied in 
the context of the general cell life cycle. However, how pathogens initiate, and 
subsequently counteract host-mediated restrictions limitations are not fully understood. 
Further elucidation of the induction and maintenance of host cell defense mechanisms 
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during pathogenesis, and assessing how pathogens evolve to disrupt such limitations, will 
aid in the development of therapeutics against disease. 
Intrinsic innate immunity 
 The first response against the virus after entry is initiated occurs within the 
infected cell itself. This response requires an immediate and direct response, called 
“intrinsic innate immunity,” which defines factors that immediately recognize viral 
components and restrict infection and/or replication [1]. This response consists of 
cytosolic pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and 
Rig-I-like receptors (RLRs), as well as host restriction factors that are either 
constitutively expressed within the cell at basal levels, or proteins whose expression is 
upregulated relatively quickly through IFN signaling. 
 Some examples of intrinsic innate immunity factors include IFN-inducible 
transmembrane proteins (IFITMs) that restrict influenza virus [2, 3] and the myriad of 
factors that attempt to restrict HIV uncoating and reverse transcription during entry, such 
as TRIM5 [4] and APOBEC3G [5]. Other factors such as cGAS and DDX41 sense 
incoming foreign DNA, such as viral genomes, and activate STING-dependent signaling 
cascades to produce interferons [6-11]. Defensins also inhibit virus infection by 
restricting their entry, yielding yet another pathway hosts utilize to mediate infection [12-
14]. Viruses often utilize varied strategies to evade these host elements, establish an 
infection, and replicate. The presence, or indeed absence, of certain factors in some cell 
types may in part determine the permissiveness of a cell to succumb to viral infection. 
Co-evolution of a virus with its host counterpart places immense positive selection 
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pressure on both organisms to best each other, in a sort of virus-host “arms race.”  For 
these reasons, studying the mechanisms by which these factors are activated and 
subsequently recognize and restrict virus entry is critical for the future development of 
antivirals. In depth studies of both the host factors or complexes that restrict viruses, as 
well as the viral proteins critical for evading these responses, will not only shed light on 
the complex interactions between the two, but may also further investigations into 
parallel host-virus interactions that currently elude us. 
Innate immune responses to pathogen infection 
 In addition to immediate response factors, the host cell contains a multitude of 
sensors to detect non-self components expressed by pathogens. Activation of these 
sensors results in stimulating an equally complex set of signaling pathways, and 
ultimately changes in host protein expression or function both within the infected cell, 
and also alerts neighboring cells to the presence of a pathogen. Host PRRs recognize both 
pathogen-associated molecular patterns (PAMPs) from infectious agents as well as 
conserved danger molecules produced by the cell in times of stress (danger-associated 
molecular patterns, or DAMPs). These unique patterns, though structurally diverse, are 
conserved across many pathogens, and require differential recognition by PRRs via 
distinct ligand-recognizing domains. PRRs are characterized by structure, specificity, 
cellular localization, and tissue-specific expression. Currently identified PRRs are 
grouped into multiple classes, including membrane-localized TLRs, RLRs, C-type lectin 
receptors (CLRs),  intracellular NOD-like receptors (NLRs), and cytosolic nucleic acid 
sensors such as the Pyrin-HIN domain-containing family, OAS proteins, and cGAS [15-
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20]. There are also soluble, secreted PRRs, such as oligosaccharide-binding collectins, 
that recognize moieties on microbial cell surfaces and allow macrophages and neutrophils 
to phagocytose them. 
Interferon signaling 
 Innate detection of incoming virions at the cell surface or within the cytoplasm by 
PRRs initiates downstream pro-inflammatory effectors that consequently put neighboring 
immune cells – including macrophages, monocytes, neutrophils, and NK cells – in an 
alerted antiviral state within hours of the initial infection [21, 22]. For example, several 
TLRs present on the cell surface and within endosomal membranes recognize viral 
moieties, eliciting signals that activate the transcription factors IRF3 and NF-κB to 
enhance Type I interferon (IFN) expression [22, 23]. Produced IFNs are secreted and act 
as ligands for neighboring cells, subsequently inducing an antiviral state in the nearby 
cells through the induction of antiviral interferon-stimulated genes (ISGs), as well as 
contributing to an adaptive immune response [24]. There are three known classes of 
interferons: type I IFNs consist of IFN- and IFN-β, the type II IFN class has only one 
member (IFN-γ), and type III IFNs contain of three distinct molecules of IFN-λ [25]. 
Type I and type III interferons have predominant roles during viral infections, and are 
produced by nearly every cell type upon recognition of a viral moiety [26-28]. 
Proinflammatory Responses 
 In addition to IFN production, viral penetration into cells may result in the 
production of proinflammatory cytokines, such as IL-1β, TNF-, and IL-6. These 
proinflammatory cytokines activate an antiviral response and recruit other immune cells 
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such as macrophages and neutrophils. A class of NLRs recognize virus and oligomerize 
into a structure called the inflammasome, which associates with caspase-1 to cleave it 
into its active form. Active caspase-1 subsequently cleaves pro-IL-1β and pro-IL-18 into 
mature IL-1β and IL-18, facilitating their secretion [29-31]. Studies suggest that reactive 
oxygen species (ROS) produced upon oxidative stress within the cell is an important 
factor during inflammasome activation [32]. Protein kinase R (PKR), a host molecule that 
recognizes viral RNA in cells, is implicated in positively regulating NLRP3 
inflammasome activation, though the mechanism is unknown [33-35]. In addition to 
inflammasome formation, NLRs have a myriad range of functions during pathogen 
infection. It activates a number of signaling pathways, including p38 mitogen-activated 
protein kinase (MAPK) and ERK stimulation, which activate NF-κB-dependent 
transcription to produce inflammatory chemokines such as CXCL10 and CCL5 [36-38]. 
These chemokines are important to recruit immune cells to sites of inflammation, 
initiating the adaptive immunity arm of the immune response. NLRP3 inflammasomes 
also have the capacity to initiate cell death through pyroptosis as a sort of “self-destruct” 
if the cell is succumbing to microbial infection [39].  
Adaptive immunity 
 Well-established literature indicates that PRR signaling and inflammasome 
activation are critical factors in controlling the development of the adaptive immune 
response upon intracellular pathogen exposure. After the initial response to infection, the 
production of IFNs and inflammatory cytokines and chemokines stimulate and recruit 
adaptive cells to the site of infection, and direct an immune response that is highly 
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specific towards the infecting pathogen [40]. While the explicit roles of specific classes 
of PRRs in inducing the adaptive immune response are still not entirely clear, current 
data indicate that PRR-mediated signaling guides the specific actions induced during the 
adaptive response. For example, PRR signaling in dendritic cells (DCs) governs the 
particular antigens presented to T and B cells, as well as help to dictate the effector 
proteins produced by lymphocytes during infection [41]. The combinations of recognition 
by individual innate immune molecules and how effector cells of the adaptive immune 
system interpret the given signals are key factors in generating the appropriate type of 
effector response. 
Pathogen recognition and signaling by DCs also play a clear role in effector T cell 
maturation, as mouse models lacking specific populations of functionally distinct DC 
subsets generate varying T cell responses [42-44]. Indeed, direct PRR activation within a 
DC subset is required to activate specific helper T cell responses [45]. Resident antigen 
presenting cells (such as DCs) take up antigen and display antigenic epitopes MHC class 
II molecules to the local lymphatic system [46]. Antigen presentation to naïve CD4+ T 
cells in a lymph node engages the T cell receptor (TCR), and CD80/86/CD28 
ligand/receptor costimulation on T cells, as well as IL-18 and IL-12 cytokine secretion 
skew lymphocyte differentiation to CD4+ T helper type 1 cell (TH1 cell) populations [40]. 
TH1 cells produce IFNγ to facilitate antibody class switching in activated B cells to 
opsonizing IgG classes and support CD8+ T cell activation [47]. Other T helper cell 
populations are induced upon extracellular infection (TH17 cells) or B cell interactions 
and allergic responses (TH2 cells). Activated effector helper T cells have the capacity to 
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interact with B cells, providing necessary signals (both direct and indirect) to facilitate B 
cell proliferation and maturation into antibody-secreting plasma cells [48]. A small subset 
of these T cells also generate a population of memory cells that persist within the host 
long after the infection is cleared, and offer a source of rapid protection upon 
encountering the same antigen [49]. 
During intracellular pathogen infection, infected cells express antigenic epitopes 
loaded onto MHC class I molecules, which are expressed in virtually all nucleated cell 
types. CD8+ cytotoxic T cells (CTLs) recognize antigens in the context of MHC class I 
molecules, and costimulation activates CTLs to facilitate killing of the infected cells [47]. 
CTL-mediated cell death is effected by T cell release of perforin- and granzyme-
containing cytolytic granules, which lead to cell apoptosis. Recent reports suggest that in 
addition to cytolytic effects, a subset of memory CD8+ T cells also have the ability to 
provide T cell help. Upon re-exposure to a pathogen, these cells produce IL-4 and other 
cytokines to support B cell migration to sites of infection, subsequently activate the B 
cells and facilitate antibody class switching [50, 51]. 
 Many studies use viruses and other pathogens to study changes in the immune 
response during infection, with a substantial focus on adaptive responses and long-term 
immunity. However, current efforts have shifted to using certain viruses as tools to 
deliver transgenes into host cells for both gene therapy and vaccine development [52]. 
Years of co-evolution have developed viruses into operational nanomachines that are 
already extremely effective at delivering genetic material. Using viruses as a pre-existing 
platform for gene delivery requires a dynamic change in research focus: in addition to 
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studying broad adaptive host responses, also investigating more deeply the intrinsic 
innate responses against initial infection to allow optimal transgene delivery, and immune 
responses thereafter. Such a reassessment of each individual step of the immune response 
as a whole, as well as their interplay with each other to produce an optimal response 
against transgene expression, will allow researchers to develop very specific and targeted 
viral platforms as vaccine candidates. This dissertation will focus on some components of 
the initial host restriction of adenovirus (Ad), as well as viral mechanisms of evading 
such restrictions. 
Autophagy as an innate antimicrobial response 
One particular intrinsic innate immune response is a regulatory mechanism called 
autophagy. Autophagy is a host process generally utilized by the cell to sequester excess 
or damaged cytoplasmic macromolecules and host organelles, typically to facilitate 
degradation of these complexes. Three main forms of autophagy occur within the cell: 
macroautophagy, microautophagy, and chaperone-mediated autophagy [53]. 
Macroautophagy (referred to as simply autophagy henceforth) is the most studied type, 
and forms a double-membraned vesicle, or autophagosome, around cytosolic contents to 
sequester them. Degradation of these contents occurs upon autophagosomal fusion with 
another vesicular compartment, the lysosome [53]. Low pH and high concentrations of 
hydrolytic proteases, sulfatases, and glycosidases break down lysosomal contents to 
provide free amino acids for de novo protein synthesis. 
In addition to autophagy’s necessity during the general cell cycle, it also serves a 
role as a defense mechanism against numerous intracellular pathogens (called 
  
9 
xenophagy). Cell sensing of pathogen invasion through different pathways ultimately 
elicits autophagosome formation to isolate and degrade pathogens [54]. This function is 
important for innate immune responses during viral infections, as degradation exposes the 
viral genome to TLRs, and DNA recognition leads to downstream production of Type I 
IFNs. Due to this fact, many pathogens have evolved means to inhibit or exploit 
autophagosome formation during infection. For example, multiple bacterial pathogens 
evade being targeted to autophagosomes by replicating undetected within vesicles, 
isolated from the cytoplasm and much of the autophagy-inducing machinery. 
Additionally, almost all known viruses utilize varied methods to circumvent restriction by 
autophagy. Some DNA viruses, such as HSV-1, HCMV, and KSHV all suppress 
autophagy activation almost entirely. Others, including EBV, SV40, VZV, and hepatitis 
B viruses induce autophagy during infection, but readily evade restriction [55]. On the 
other hand, many RNA viruses colocalize with autophagic membranes during replication 
[56], suggesting their utilization and exploitation of this host cell defense. 
It has become clear that basal levels of autophagy are not sufficient to restrict 
intracellular pathogen infection, and as such research has recently begun to investigate 
the specific signals required to induce autophagosome formation. One major signaling 
pathway molecule involved in autophagy induction during bacterial infection is the 
kinase mammalian target of rapamycin (mTOR). In Shigella, Listeria, and Salmonella 
infections, membrane damage inflicted by these pathogens rapidly inhibits mTOR, 
enhancing autophagy induction. Increased autophagosome formation is persistent in the 
case of Shigella-induced damage, but both Listeria- and Salmonella-mediated rupture see 
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a transient increase [57-59]. Interestingly, the Salmonella pathogenicity island 1 (SPI-1) 
recruits the host kinase focal adhesion kinase (FAK) to activate mTOR activity [60]. This 
likely mediates the transient mTOR inhibition observed during Salmonella infection. 
Other, mTOR-independent autophagy induction pathways are also implicated in pathogen 
restriction. Beclin-1 complex activation through the PI3 kinase signaling pathway 
enhances autophagosome formation, as evidenced by multiple viruses incorporating 
genes that specifically regulate this complex [61-67]. These observations indicate that 
numerous pathways are in place to activate autophagosome-mediated restriction of many 
different pathogens. The fact that the majority of intracellular pathogens evolved 
mechanisms to evade this response is significant, implicating autophagy as a major player 
in restricting intracellular pathogen infection during cell entry. 
How the host specifically recognizes and targets pathogens to autophagosomes is 
diverse, depending on the organism, and these various approaches are currently under 
investigation. Nod1 and Nod2 proteins recognize peptidoglycan moieties on bacterial 
pathogens contained within vesicles. This detection leads to downstream signaling 
events, activating NF-κB and mitogen-activated protein kinase (MAPK) pro-
inflammatory pathways in a Rip2-dependent manner [68, 69]. Nod2 also interacts with 
the autophagy component ATG16L1 in a Rip-2-indpenedent manner, recruiting it to 
bacterial-containing vacuoles near the plasma membrane [70]. While current data clearly 
implicate Nod proteins in targeting bacteria contained within vesicles, it is unclear 
whether they also have the ability to sense bacteria that have escaped into the cytosol. 
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In the case of pathogens requiring membrane rupture to access the cytosol, our lab 
and others suggest that galectin recruitment is an important nucleating event to induce 
autophagosomal targeting. Galectin-3 is reported to colocalize with the autophagosomal 
marker, LC3, after membrane rupture during Shigella infection [71]. Upon endosomal 
lysis by Salmonella enterica, galectins 3, 8, and 9 are all recruited to the site of injury, 
and of these three, siRNA knock down of only galectin-8 significantly limits LC3 
recruitment to Salmonella-containing vacuoles and increases bacterial replication [72]. 
This report also showed that galectin-8 recruitment of NDP52 occurs more rapidly than 
ubiquitin-mediated recruitment. These studies suggest that galectin-8 binding damaged 
membranes facilitates a rapid recruitment of other factors important for autophagy 
induction.  
Ubiquitin may also play a vital role in LC3 recruitment. Upon rupture, various 
proteins from both the host and the pathogen become polyubiquitinated by host proteins 
[72, 73]. The E3 ubiquitin ligase leucine-rich repeat and sterile alpha motif-containing 1 
(LRSAM1) ubiquitinates Salmonella organisms, and this ligase’s activity is necessary for 
recruiting NDP52 [74]. Knock down of LRSAM1 increases Salmonella replication within 
Salmonella-containing vacuoles (SCVs), but its function in other infection models has not 
been assessed. Furthermore, Salmonella de-ubiquitinating (DUB) activity interferes with 
autophagy, suggesting that ubiquitination is necessary for autophagy-mediated restriction 
[75, 76]. Data support that ubiquitin acts as part of a protein “bridge” to enhance LC3 
membrane association with pathogens (discussed below). Inhibiting global protein 
ubiquitination by a chemical inhibitor of E1 ubiquitin activating enzymes severely 
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restricts LC3 recruitment to ruptured endocytic membranes during transfection of 
polystyrene beads, where, presumably, the transfection reagent is rupturing endosomes 
[77]. The authors argue that since the beads are not proteinaceous, and thus cannot be 
ubiquitinated, then it is host protein ubiquitination that recruits autophagy machinery. In 
live-cell imaging experiments, LC3 recruitment to ruptured membranes occurs up to 15 
minutes after protein ubiquitination, and knocking down autophagy machinery has no 
effect on membrane fragment ubiquitination. 
After ubiquitination, so-called adaptor proteins have the capacity to bind ubiquitin 
and subsequently recruit LC3, targeting ubiquitinated targets to initiating 
autophagosomes. At present, four proteins are identified as adaptor proteins: p62, 
NDP52, NBR1, and optineurin (OPTN) [78-81]. NDP52 binding to ubiquitinated 
molecules recruits a protein complex including the host kinase TANK-Binding Kinase-1 
(TBK1). TBK1 phosphorylates p62 and OPTN to increase their affinities for LC3 after 
binding ubiquitin [81, 82]. It is unknown whether NBR1 is phosphorylated by TBK1. 
Preventing TBK1 function in MEFs either through siRNA knock downs or chemical 
inhibition increases the number of autophagosomes within the cell, but prevents their 
maturation and fusion with lysosomes [83]. This indicates that TBK1 function occurs 
after autophagy is induced, but is important in their maturation process. The importance 
of TBK1 in infections has precedence in both bacterial and viral contexts. TBK1 is a 
critical factor in limiting replication in a number of bacterial pathogens via 
autophagosomal maturation, and HIV accessory proteins Vpr and Vif block TBK1 
autophosphorylation to inhibit the induction of both Type I and Type III interferons [82-
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86]. These data suggest that TBK1 is critical not only for autophagosome sequestration of 
pathogens, but also plays a role in interferon production during infection. Interestingly a 
second host kinase, Unc-51-like kinase (ULK1), also phosphorylates p62 at S409 [87], 
but biochemical assays indicate that p62 phosphorylation by ULK1 inhibits TBK1-
mediated phosphorylation on S403 [88]. Casein kinase 2 (CK2) also phosphorylates S403 
[89], suggesting that CK2 phosphorylates p62 as an alternative to TBK1 in this case. It is 
noteworthy that both ULK1 and CK2 phosphorylation of p62 occurs through mTOR 
signaling. Perhaps TBK1-dependent phosphorylation of p62 is important in mTOR-
independent autophagy induction pathways. Nevertheless, a number of reports clearly 
implicate the importance of TBK1 phosphorylating activity in retaining pathogens to 
autophagosomes. 
Microtubules 
The microtubule network 
 Microtubules (MTs) are one of three cytoskeletal networks in the cell, along with 
intermediate filaments (IFs) and microfilaments (actin) [90, 91]. MTs are a major 
component of trafficking various molecules throughout the cell, including protein 
complexes, cytoskeletal components, various membrane-bound organelles, and even 
pathogens. Cargo motilities on MTs are some of the fastest in the cell, and are composed 
of both short- and long-range, directional movements. They maintain cell shape, 
influence cell movement, and separate chromosomes during cell division. Their assembly 
is dynamic, consistently depolymerizing (catastrophe) and re-polymerizing (rescue). This 
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complex oscillation of short and long structures is important for reorganizing the cell, 
especially during mitosis. 
MTs are tubular, helical rods consisting of dimers of globular proteins - and β-
tubulin that extend from the microtubule organizing center (MTOC) near the nucleus 
throughout the cell cytoplasm [92]. A third form of tubulin, γ-tubulin, anchors MTs at the 
MTOC and initiates the polymerization of new MTs [93]. Dynamic instability of MTs 
allows the cell to quickly alter and modify the cell’s architecture. MTs are polar 
structures, containing a minus end anchored at the MTOC, and a plus end that extends 
outward where nascent tubulin dimers are added. Catastrophe and rescue preferentially 
occur at MT plus ends. /β-tubulin dimers bound to GTP readily associate to MT plus 
ends, supporting MT growth. Rho GTPases hydrolyze GTP on MT-associated tubulin, 
diminishing its affinity to maintain an interaction with other tubulin molecules [94, 95]. 
Growth and/or destabilization of microtubules depends on both the rates of tubulin 
addition to MT plus ends as well as GTPase activity. As long as GTP-bound dimers are 
added at a faster rate than GTP hydrolysis occurs, microtubules retain a GTP-capped plus 
end, continuing growth. Once a critical concentration of GDP-bound tubulin is reached 
due to increased GTPase activity or decreased tubulin availability, the MT quickly 
depolymerizes, shrinking back toward the MTOC. Most MTs undergo rapid turnover, 
having a half-life of approximately a few minutes. 
Microtubule motor proteins facilitate transport throughout the cell 
Travel throughout the cell upon microtubules is mediated by two families of 
motor proteins: cytoplasmic dynein (hereafter referred to simply as dynein) complexes, 
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and protein complexes from the kinesin superfamily [96, 97]. With very few exceptions, 
dynein molecules traffic cargo in a retrograde fashion towards MT minus ends (i.e., the 
MTOC and nucleus), and kinesin complexes transport molecules anterogradely to the cell 
periphery, towards MT plus ends. Many kinesin motors exist, and are differentially 
expressed in humans based on cell type. However, current research suggests that only one 
gene exists for the dynein motor, expressed ubiquitously in all cell types [98]. Most 
cargoes simultaneously interact with dynein and kinesin motors, with directional 
transport towards the proper destination mediated by back-and-forth movements along 
MTs culminating in an overall net course [99]. This method of travel likely allows the 
motors to avoid obstructions in its path, such as overlapping MTs or MT-bound proteins 
in the way. Alternatively, it may provide a means around an all-or-nothing decision of 
material transport, whereby the cargo reaches its end point via numerous, small 
movements, grossly culminating towards the proper direction. The interplay between 
these two groups of motors is complex, and their functions are absolutely necessary for 
cell viability.  
Dynein motors are a large (1-2 MDa) complex of proteins made up of a motor and 
various molecules that direct cargo specificity. The dynein heavy chain (DHC) is the 
central component of the complex, and contains the motor function of the complex at its 
C-terminus and an N-terminal tail domain, responsible for interacting with other complex 
components [100]. The motor domain is made up of a microtubule-interacting stalk and 
six AAA+ (ATPase associated with diverse cellular activities) domains, arranged in a 
ring-like structure. ATP hydrolysis generates force to move dynein and its cargo. The 
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mechanism of converting energy from ATP to ADP to generate such a force is not well 
understood, although recent advances suggest that ATP hydrolysis acts in concert with 
dynein attachment to, and detachment from, microtubules, coordinated by open and 
closed conformations of the AAA+ ring [101, 102]. 
A dimer of two DHCs makes up the core of the dynein complex. The tails of each 
dimer bind both two intermediate and two intermediate light chains (IC and LIC, 
respectively). IC and LIC genes contain multiple alternative splice sites, producing a 
range of tissue-specific isoforms that potentially enact different functions [103-105], 
including differential interactions with other dynein complex proteins [106]. Different 
isoforms of ICs localize dynein to varying organelles, and research suggests that neuronal 
cells discriminate dynein motors based on the specific variants of ICs present. Isoforms 
can also heterodimerize on dynein, potentially increasing potential cargo interactions for 
that motor. IC and LICs subsequently bind two of three distinct light chains (LCs): Tctex-
1, LC8, and LC7/Roadblock. Additionally, dynein interacts with a number of regulators, 
including dynactin, Lis1, NudE, and NudE-related proteins Nde1 and Nde2. These 
regulators control a number of aspects of dynein function, including microtubule 
association during spindle assembly and cargo specificity. Dynactin in particular, which 
is itself a complex of proteins, is a cargo-binding subunit critical for normal dynein 
function. Point mutations in the dynactin subunit p150Glued cause a Parkinson-like 
disease, Perry syndrome [107]. 
Kinesins are a superfamily of proteins; 14 classes contain approximately 45 
different genes. Similar to dynein, a dimer of kinesin heavy chains (KHCs) make up the 
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core of the complex, which also contain an ATP-hydrolyzing motor complex and protein-
binding tail [98]. The motor domain is highly conserved among kinesins, but the tail is 
highly variable. Most kinesins move anterogradely along microtubules, but observations 
show that some types move towards the nucleus, and others even affect microtubule 
shrinking and growth. This study focuses on an isoform of a major kinesin molecule 
Kinesin-1, Kif5B. Interestingly, kinesin molecules maintain themselves in an auto-
inhibited state when they are not transporting cargo, where the tail domain folds in over 
the motor head [108]. Interactions with cargo or phosphorylation by regulatory kinases 
unfold kinesin, activating its motor function. Evidence also implicates RanBP2 (also 
known as the nucleoporin Nup358) as an activator of Kif5B function [109, 110]. 
The structure of the kinesin complex is comparable to that of dynein: KHC 
molecules dimerize through coiled-coil interactions, and, via their tail domains, 
subsequently interact with two kinesin light chains (KLCs), which control cargo 
specificity. In humans, there are four distinct isoforms of KLC: KLC1, KLC2, KLC3, and 
KLC4 [111]. KLC1 and KLC2 are the most-studied light chains. They are ubiquitously 
expressed in various tissues, and share 87% sequence identity between their cargo-
binding domains. KLC cargo binding depends on the interactions of proteins with 
tetratricopeptide repeat (TPR) domains, which are helical tandem repeat structures 
consisting of 42 amino acids. KLC1 contains six TPRs, while KLC2 totals 5 and one-
half, leading to slightly different cargo specificities. 
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Microtubule post-translational modifications 
Although the makeup of MTs seems simple, they are involved in a vast number of 
applications in the cell. To accomplish all of these functions, MTs are regulated by a 
number of mechanisms, most notably post-translational modifications (PTMs) [112, 113]. 
The multitude of PTMs that occur on MTs affect their dynamic stability, as well as the 
molecules they selectively recruit and bind. Some PTMs are ubiquitous, such as 
acetylation and phosphorylation, functioning as binary on/off switches. Others are 
potentially unique to microtubules, including tyrosination and glutamylation. PTMs have 
the capacity to occur concurrently, giving a vast complexity to the functions of individual 
MTs. Most PTMs, with the exception of acetylation, occur on the outside surface of the 
MTs, modifying the C-terminal tails of the tubulin molecules. In contrast, acetyl-
transferases modify the lumenal surface of MTs. 
Mouse cells deficient in acetylated MTs are more resistant to nocodazole 
treatment, and β-tubulin acetylation on its lysine residue at position 252 inhibits 
microtubule rescue, leading some to postulate that acetylation likely does not regulate the 
binding of motor proteins or other microtubule-associated proteins (MAPs), but regulates 
the assembly of nascent MTs [114, 115]. However, a more recent report indicates that 
acetylation enhances p38-MAPK activation in macrophages, and increases Hsp90 
recruitment to MTs. The data suggest that Hsp90 binding activates Akt and p53 signaling 
[116]. Studies also show that both - and β-tubulin subunits are phosphorylated, however 
the exact function of this activity is unknown. Phosphorylating β-tubulin at residue S172 
may play a role in regulating MT dynamics during cell division, but no function has been 
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attributed to -tubulin phosphorylation [117]. Other common PTMs seen on MTs include 
methylation, palmitoylation, ubiquitination, and sumoylation, although no functions 
involving these modifications have been revealed. 
Microtubule tyrosination is the reversible act of appending a tyrosine residue to 
the C-terminal end of unpolymerized tubulin molecules [117, 118]. Tubulin sequences 
reveal that tyrosine is initially encoded within -tubulin, suggesting that tyrosine 
removal, or detyrosination, is the initial modification. The mechanism of detyrosination is 
yet to be revealed, but tyrosination occurs via the tubulin tyrosine ligase, or TTL. 
De/tyrosination activity is a critical function in development, as TTL-deficient mice die 
within 24 hours after birth. A number of functions are attributed to tubulin detyrosination, 
which leaves the penultimate glutamate residue as the terminal amino acid. It modulates 
the interactions of MTs with both various MAPs and other cytoskeletal filaments. 
Detyrosination also restricts MT turnover by negatively regulating the mitotic 
centromere-associated kinesin (MCAK), which rapidly depolymerizes microtubules 
[112]. It also reduces kinesin-1 processivity, but enhances kinesin-2 recruitment [119]. 
On the other hand, tyrosinated tubulin is important for spindle formation, implicating its 
importance in mitosis [112]. These differences in functions suggest that the addition and 
removal of tyrosine to the C-terminus of tubulin molecules is an essential regulator of 
microtubule activity and stability. In fact, another PTM that modifies the C-terminal tail 
of proteins is the removal of either one or two glutamate residues after detyrosination 
(Δ2-tubulin and Δ3-tubulin, respectively) [120]. Studies into these modifications are not 
fully fleshed out, but in rat neuronal cells they are indicative of very long-lived 
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microtubules [121]. These molecules cannot be re-tyrosinated after glutamate removal, 
indicating that at least one of the roles of glutamate removal is to enhance microtubule 
stability by preventing the addition of tyrosine. 
Two other PTMs that occur on tubulin are polyglutamylation and polyamination, 
which add side chains of glutamates or amines, respectively, to gene-encoded glutamate 
residues [122, 123]. Chains are typically appended to C-terminal amino acids, and are 
hypothesized to regulate electrostatic interactions between MTs and associated proteins 
by changing the charge on the MT surface, although no experimental evidence yet 
supports this claim. Large glutamate chains (Glu10) appear to decrease kinesin-1 
processivity, but shorter chains (Glu3) do not enact this effect [119]. Synthetic assemblies 
suggest that polyglutamylation also enhances dynein processivity, but the relevance of 
this in vivo has not been pursued. Additionally, polyglutamylation reduces MT stability 
while polyamination enhances it, especially in MT destabilizing conditions induced by 
cold or calcium-containing environments. Interestingly, while polyglutamylation is a 
reversible process, polyamination is likely irreversible [112, 113]. More research into 
these modifications is required to understand their specific contributions to microtubule 
function during the cell cycle. 
The endosomal pathway and microtubule trafficking 
MT networks are vital in sustaining the transport of endocytic vesicles throughout 
the cell. Every endosome actively moves throughout the cell on MTs, and transport is 
dependent on the type of endosome [124]. Extracellular contents are taken up by 
EEA1+/Rab5+ early endosomes (EEs), which are formed at the plasma membrane, 
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generally in an actin-dependent manner [125]. The actin motor myosin VI, along with 
+TIP proteins EB1, EB3, and CLIP-170, passes newly-formed EEs from the actin cortex 
to MT-associated dynein via dynactin, where the endosome traffics to the cell interior 
[126, 127]. EEs undergo a quick drop in pH to between 6.8 and 6.1 upon trafficking to, 
and fusing with, early sorting endosomes [128]. Here, competing interactions between 
dynein and kinesin molecules are important for membrane fission of newly-formed 
recycling and late endosomes (LEs) [129-131]. Vesicle contents are sorted into either 
Rab4+ or Rab11+ recycling endosomes, or sent on to mature into Rab7+ LEs [132, 133]. 
The majority of endocytose molecules are sent back to the cell surface through recycling 
endosomes. Recycling endosomes colocalize with the kinesin-13-family molecule 
Kif13A, and kinesin traffics the cargo of these vesicles back to the plasma membrane or 
to the trans-golgi network (TGN) [134]. 
LEs are sent towards a more destructive pathway, targeting their contents to 
lysosomes for degradation. These vesicles are bidirectional, suggesting the use both 
kinesin and dynein molecules to move throughout the cell, although direct interactions 
with kinesin have not been shown [135]. Dynein binds LEs via dynactin interactions with 
Rab7-interacting lysosomal protein (RILP) and the oxysterol-binding molecule ORP1L 
[136]. LEs mature in the span of less than an hour, sustaining various modifications: 
They increase in size; intralumenal vesicles (ILVs) bud into the LE via ESCRT 
machinery, sorting ubiquitinated proteins into smaller vesicles for easier degradation; 
Rab5 is switched out for Rab7, altering its function and recruiting novel effector 
molecules, such as RILP to bind dynein and LAMP1 to protect the limiting membrane 
  
22 
from degradation; and the vesicle is further acidified to approximately pH 4.8, to assist its 
fusion with very low-pH lysosomes [137]. At this point, LEs typically continue on to fuse 
with lysosomes and degrade their contents, although they may also traffic back to the 
plasma membrane to release their ILVs into the extracellular milieu as exosomes [138]. 
Lysosomes traffic throughout the cell by way of both dynein and kinesin-1 Kif5B 
activities [139, 140]. 
Intracellular pathogens commonly exploit microtubule functions 
 There is considerable pressure on a cell to maintain the functions and activities of 
MTs and their associated proteins for viability. To this end, many intracellular pathogens 
have evolved mechanisms to make use of MTs in their own way, either for entry, 
replication, immune evasion, or combinations thereof. Viruses generally exploit MTs by 
hijacking motors to reach their preferred site of replication. Both HSV1 and pseudorabies 
virus (PrV) establish latent infections in cells via transport to the nucleus on MTs by way 
of their tegument proteins [141-144]. Efficient infection with these viruses requires 
dynein function [145, 146]. Furthermore, purified HSV-1 capsids directly bind kinesin-1 
and kinesin-2 molecules [147], however this interaction requires inner tegument proteins 
since capsids purified from nuclear extracts do not bind the motors. Vaccinia virus (VV) 
also uses kinesin-1 to move immature enveloped virions (IEVs) from viral replication 
factories near the nucleus to the cell surface, where they acquire a second membrane 
envelope and exit the cell [148]. Research suggests that a VV protein, F12, mimics the 
structure of kinesin light chain, binding the KHC directly to mediate transport [149, 150]. 
Alternatively, another VV protein, A36, binds KLC TPRs, suggesting the virus interacts 
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with fully complexed kinesin molecules for egress [151]. Upon entry into the cytoplasm 
after envelope fusion with the cell surface, HIV core complexes exploit microtubule 
networks for cell transport. While the complex requires dynein to move to the MTOC, it 
is unclear how this occurs [152]. While some have implicated that the HIV capsid 
protein, p24, is important for MT associations, others have pointed out that capsid 
availability on the core is unstable and rapidly disassembles as reverse transcription 
occurs [152, 153]. 
 Bacterial pathogens can also use MT motors to move within the cell as well, 
although some produce factors to destabilize microtubules entirely. Shigella bacteria 
utilize their type 3 secretion system (T3SS) to introduce the effector molecules into host 
cell cytoplasm. One effector molecule, VirA, reportedly degrades -tubulin monomers, 
destabilizing MTs and enhancing bacterial entry and movement within the cytoplasm 
[154-156]. Although it does not have the ability to actively destabilize MTs, Chlamydia 
produces CopN to directly sequester monomeric - and β-tubulin molecules, inhibiting 
the formation of new MTs [157, 158]. Still other bacteria have the ability to completely 
rearrange the MT network architecture for their own ends. Listeria, which is commonly 
known for its visible comet-shaped actin “tails,” reassigns dynamin-2 to aid in its 
movement [159]. Dynamin-2 is a GTPase utilized by the cell to properly bundle MT 
filaments for cell motility [160, 161]. Salmonella completely usurps microtubules using 
its effector molecule SifA. Secreted via T3SS, SifA reforms microtubules entirely into 
tubules that form around SCVs, called Salmonella-induced filament (SIFs) [162]. 
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Effectors SseG and SSeF induce further microtubule bundling, however the specific 
details of MT restructuring is unclear. 
 Collectively, these examples showcase a clear dependence of both cells and 
pathogens on the microtubule network. Using these pathogens as tools to systematically 
examine the processes required for the regulation and maintenance of MTs will aid our 
understanding of both the host cell activities requiring MTs as well as the mechanisms of 
pathogenicity by various infectious agents. 
Adenoviruses 
 Adenoviruses (Ads) are icosahedral, non-enveloped, linear double-stranded DNA-
containing viruses belonging to the genus Mastadenovirus. Since their original isolation 
from adenoid tissue in 1954, more than 60 human Ad serotypes have been identified and 
categorized into 7 subgroups (A-G) based on sequence homology, oncogenecity in 
rodents, pathogenicity, serum neutralization, and hemagglutination properties [163-169]. 
Initially identified as a causative agent of acute respiratory disease (ARD), reports 
indicate that some serotypes cause gastrointestinal, ocular, or urinary tract infections as 
well [170, 171]. Although some human species cause oncogenicity in rodents, there is no 
indication that they cause tumorigenesis in human cell lines [172, 173]. Depending on the 
subgroup, the adenoviral genome varies from 30-40 kbp in size and encodes 
approximately 40 genes (Table). Adenovirus infection is a useful tool to probe cellular 
processes, study intrinsic immune responses of the host cell to virus infection, and further 
understand mechanisms evolved by viruses to evade detection and restriction. This study 
focuses on a subgroup C virus, Ad5. 
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Adenovirus capsid 
The Ad capsid is a 90nm wide, icosahedral capsid made up of 12 structural 
proteins (Figure 1). The icosahedral shape gives the capsid 2-, 3-, and 5-fold symmetries. 
The major capsid protein, hexon (protein II), makes up the majority of the viral shell in 
720 copies, forming 240 trimers (20 facets, 12 trimers per facet) [174, 175]. Located at 
each of the twelve vertices of the capsid is the penton complex, made up of penton base 
(protein III), anchoring trimers of the fiber protein (protein IV). Two more so-called 
minor capsid proteins, protein VIII and protein IX, stabilize the integrity of the capsid. 
Proteins VI and IIIa are contained just below the surface of the capsid shell [168], and act 
as a sort of secondary lattice. Protein VI interacts with the core protein V, which is 
associated with the viral dsDNA genome, and is delivered to the nucleus along with the 
DNA. Five other proteins are found on the interior of the capsid along with the genome: 
protein VII, Mu (μ) protein, protein IVa2, the terminal protein (TP), and the adenoviral 
protease. 
The capsid of mature virions can be pictured as having three layers, so to speak:  
an outer layer, an inner layer, and the genome-containing interior [176]. The interior of 
the virion contains the genome and the core proteins pV, pVII, μ, pIVa2, a viral protease 
and TP [177-181]. This region is highly disordered, and thus not crystallized, suggesting 
the genome is not as tightly packed as other viral genomes such as herpes viruses or 
bacteriophage. The C-terminus of pV, however, is ordered at the inner layer of the capsid, 
found in a ternary complex with pVIII and pVI at the vertex region [176]. The current 
model depicts pV as a bridge between the DNA core and the capsid shell, where the 
  
26 
basic, disordered N-terminus of pV interacts with the genome, while its C-terminus 
interacts with pVI and pVIII in the inner layer. Both μ a pVII are highly associated with 
the viral genome, and believed to be critical for proper DNA condensation and packaging 
into the capsid [182]. Although it interacts with the viral genome to efficiently 
encapsidate the DNA into developing capsids, pIVa2 is less abundant in copy number 
within the mature virion. Reports indicate that pIVa2 is a critical initiator of the viral 
major late promoter (MLP), regulating late viral gene expression and driving the 
expression of the structural capsid proteins [183]. TP facilitates viral DNA circularization 
during replication for efficient packaging into the capsid, and covalently attaches to the 5’ 
ends of the viral genome. During viral entry, TP is important for priming DNA 
replication once the virion has delivered its genome to the nucleus [184]. 
The adenoviral L3-23K protease (AVP) is important during viral replication, 
cleaving multiple viral precursor polypeptides into their active forms [185, 186]. AVP 
requires both viral DNA and a C-terminal fragment of pVI as cofactors for its proteolytic 
activity. The protease, when bound to viral DNA, interacts with the precursor form of 
pVI. It cleaves both the N- and C-termini of pVI, converting pVI into its active form. The 
C-terminal fragment of pVI (pVIc) is then utilized by AVP as a cofactor to move along 
viral DNA to encounter other viral precursor proteins, pVII, pVIII, TP and μ [187, 188]. 
Protease activity is essential to produce functional mature virions [189]. A viral mutant 
containing a temperature-sensitive form of AVP (P137L mutant, called Ad2-ts1) does not 
fold properly when replicated at the non-permissive temperature (39°C), and is unable to 
properly process viral precursor proteins [189, 190]. Virions produced at the non-
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permissive temperature are taken up by cells, but do not penetrate into the cytoplasm, 
suggesting that virion maturation enacted by the protease is essential for viral entry. 
Exposing virions to reducing and alkylating conditions prior to infection, which 
inactivates purified protease activity in vitro, reduces infectivity by nearly 5-fold, as 
assessed by plaque assay [191]. These data indicate a possible role for the protease during 
entry, after maturation. However, the effects of this treatment on other structural proteins 
is unknown, and as such the effects of this treatment cannot be directly attributed to 
protease activity. Additionally, other have shown that AVP contains both 
deubiquitinating and deISGylating activity in vitro, and global deubiquitination of 
cellular proteins occurs 12 hours post-infection [192]. Similar examinations at 6hpi 
showed no deubiquitinating activity compared to mock-infected cells, however 
deubiquitination was not examined at times corresponding to initial virion entry. Whether 
protease activity is important during entry, either through further protein processing or 
via deubiquitinating function, still remains an area worthy of investigation. 
Twenty triangular facets make up the outer layer of the capsid, with each facet 
containing a three-fold axis of symmetry. The majority of the outer layer of the shell is 
composed of hexon, with each capsid facet composed of 12 hexon trimers (referred to 
hereafter as just hexon) [193]. Hexon is organized into groups of four structurally unique 
capsomers, referred to as an asymmetric unit (AU) [194]. Each hexon within the AU is 
assigned a number, 1-4, depending on its position relative to the AU. Hexon in position 1 
is made up exclusively of peripentonal molecules, and hexon within the other positions 
make up the remainder of the face, containing nine hexon (referred to as the group of 
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nine, or GON) [195]. Hexon has trimeric symmetry on the outer surface, and the base of 
the molecule forms a pseudo-hexagon, with each edge alternatingly made up of one or 
two monomers. The formation and layout of the AUs produces eight distinct hexon-
hexon interactions, suggesting an inherently complex assembly pattern. 
Penton base and fiber proteins (collectively referred to as penton) are present in 
the outer layer of the capsid at the vertex of each facet, making up the five-fold axes of 
symmetries [196, 197]. Penton base acts as the base of the vertex, interacting with the 
five peripentonal hexons. Fiber is a long, flexible shaft protruding from the center of the 
penton base. The fiber shaft is a homotrimer making up a unique β-spiral, and extends 
approximately 300Å from the capsid, culminating in a knob at the end of the protrusion 
[198]. Both fiber and the penton base are critical for adenovirus attachment to cell 
receptors. 
Proteins pIIIa and pIX are also on the exterior of the capsid, and thought of as 
cement proteins to stabilize the capsid shell [199, 200]. pIIIa strengthens hexon-hexon 
interactions between the three hexon AUs making up each facet. There are five 
monomers of pIIIa arranged symmetrically under each penton base vertex, giving 60 
copies of pIIIa per virion. The protein is hypothesized to stabilize the capsid vertexes and 
the genome once the viral DNA is packaged into the assembled virion, as well as 
maintain the integrity of the hexon facets. Six pIIIa molecules surround each facet border 
along the two-fold axes of symmetry, with two proteins (one from each facet) stabilizing 
the interaction between a pair of facets. The protein stretches from between two 
peripentonal hexons along the outer edge of a capsid face, ending in an antiparallel, four-
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helix bundle between GON-GON interfaces. pIIIa is predicted to act as a tape measure 
protein, similar in function to the P30 protein of the bacteriophage PRD1 [201], and 
interactions between pIIIa N-termini and the L1 52-55K scaffolding protein facilitate 
genome packaging [202]. 
A second stabilizing protein, pIX, is a mainly extended molecule, stabilizing the 
interactions between hexons [203-205]. Four pIX molecules within a facet make up four 
triskelion structures: three start at the peripentonal hexon and stabilize hexons within an 
AU in a local, quasi-threefold symmetry, and one stabilizes the three AUs at the center of 
the facet in a strict three-fold symmetry. In total, the capsid contains 240 pIX molecules 
making up 80 triskelions, 60 of which make up the first type, and the other twenty 
making up the second type. Together, pIIIa and pIX make up an almost entirely 
contiguous framework surrounding the hexons within a GON [176]. 
pVI, pVIII, and pV make up a secondary lattice just underneath the outer layer 
[176]. This inner layer, while not as contiguous as the proteins making up the outer layer, 
stabilizes the hexon outer shell, including peripentonal hexons. pVIII is found in the inner 
layer as two structurally different conformations. The first forms a complex with pVI and 
pV at the capsid vertices, associating with the peripentonal hexons. The second interacts 
with pVI molecules found at hexon-2 molecules of the AU. Both conformations associate 
with the border of hexon GONs, mediating the interactions of peripentonal hexons with 
GON hexons. pVIII has also been hypothesized to act as a tape measure protein, since it 
is within the capsid interior, similar to p30 of PRD1 [201]. The final protein within the 
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inner shell is pV, which interacts with pVI and pVIII in the inner shell as well as viral 
DNA within the center of the virion. 
Previous reports implicate many varied roles for pVI, including membrane 
rupture, endosomal escape, nuclear transport, and the use of a C-terminal fragment as a 
cofactor for adenoviral protease activity in cleaving viral pre-proteins to produce mature 
virions [187, 188, 206-211]. The crystal structure of the pVI N-terminus was recently 
solved in the context of a virus, indicating one copy of pVI tightly associated with the 
base of each peripentonal hexon [176]. Five pVI molecules act as “molecular glue” 
between each peripentonal hexon surrounding a penton base, binding one peripentonal 
hexon to the peripentonal hexon from an adjacent AU, and joining them to the hexon-4 
molecule on the adjacent AU. Crystallized pVI is also found associated with hexon-2 
subunits of the AU. While the crystal structures account for approximately 120 of the 
reported ~350 copies of pVI within a mature virion, other pVI molecules may associate 
with the viral DNA that are highly disordered, and thus would not be seen in the crystal 
structure. Interestingly, while previous papers report that the N-terminus of mature pVI 
adopts an amphipathic helix important for its membrane rupture activity, this 
configuration is not present is the crystal structure of pVI within the virion. The inability 
to form a critical helical domain while inside the mature capsid may be due to 
conformational constraints within the small volume of the virion, and the amphipathic 
helix may form once pVI releases from the interior of the capsid shell and/or associates 
with endosomal membranes. 
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Adenovirus vectors as vaccines 
Adenoviruses infections are generally mild and self-limiting in healthy 
populations, but can be devastating to the elderly and immunocompromised individuals, 
such as those with AIDS or patients undergoing chemotherapy [212-216]. Since these 
infections are generally self-limiting, replication-defective Ads as vaccine vectors is 
generally regarded as safe, and as such are being thoroughly investigated [217-221]. The 
Ad genome is well-characterized, and can be manipulated relatively easily compared to 
other recombinant vectors. Ad vectors have a broad tropism, viral genomes do not 
integrate into host genomes, and elicit a potent inflammatory response. These replication-
defective vectors are deleted for E1, an essential gene for viral replication. E1-deleted Ad 
vectors are cultured in complementing HEK-293 cells, which are a transformed cell line 
containing the E1 gene. Our Ad vectors are also deleted for E3, allowing for the insertion 
of foreign DNA up to 8kb without affecting the production of viral progeny. 
The proinflammatory responses stimulated by Ad vector transduction produces 
robust adaptive immune responses in the host, including extremely potent CD8+ T cell 
activation and high antibody production [219, 222]. Intracellular recognition of 
recombinant Ad vectors by TLR activation, virus-induced damage, and cytosolic DNA 
sensors induce the production type I interferons and stimulate the secretion of a number 
of pro-inflammatory cytokines, including IL-1β, IL-6, IL-12, TNF, and IFN-γ [223]. 
These vectors by themselves induce both cellular and humoral responses, eliminating the 
necessity for additional adjuvants during vaccination. Cytokine production is independent 
of genome replication, as UV-inactivated vectors still elicit the production of these 
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molecules [224, 225]. In addition to producing a robust pro-inflammatory response, 
recombinant Ad vectors containing a transgene persistently express the protein, and is 
detectable for up to a year post administration in vivo [226]. Low level expression of the 
transgene maintains functional CD8+ effector T cell populations in the immunized 
animal, which is commonly found in persistent low level antigen expression models, such 
as persistent CMV infections. Studies also suggest that CD8+ effector memory T cell 
populations are strong correlates of disease protection. 
Ad vaccine vectors have been explored for a variety of pathogens currently of 
high interest, including HIV, Ebola, and influenza [227-229]. Current-generation Ad 
vaccine vectors exhibit high immunogenicity, but lack the efficacy to mount an optimal 
response. Many of these vectors are based on one of the most characterized serotypes of 
adenovirus, human Ad type 5 (Ad5), but more than half of the population have 
neutralizing antibodies against Ad5, limiting the capacity of these vectors to effectively 
transduce host cells [230]. To circumvent this, ongoing work is exploring the generation 
of chimeric Ad vectors that are primarily Ad5 but contain capsid epitopes from other Ad 
serotypes that are less prevalent in human populations [231]. Utilizing other so-called 
rare human serotypes that are less seroprevalent, as well as Ad species originating from 
chimpanzees, are also under investigation [232]. Another strategy under current 
development is introducing antigenic sequences into the exposed loops of hexon 
molecules called hypervariable regions (HVRs), displaying the peptide sequence directly 
on the capsid surface. Neutralizing antibodies are heavily skewed towards recognizing 
any of the seven HVR sequences, thus replacing one or more of these HVRs with 
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antigens from a vaccine’s intended target could improve antibody development against 
the organism. By employing a combination of these differing strategies, as well as 
utilizing the immunogenicity of the Ad capsid to present antigens of the pathogen of 
interest directly on the capsid surface, we can skew future generation vectors to provide a 
more beneficial response against the targeted pathogen. 
 The effects of Ads on human health – both by infection and as a vaccine – are 
substantial, however little is known about its interactions with host cells to productively 
establish an infection. Virus cell entry represents one of the first opportunities for the host 
to respond to infection. The processes of pathogen detection and restriction by the host, 
as well as strategies utilized by adenovirus to evade these constraints within its target, are 
critical events to understand to generate better therapies.  
Adenovirus cell entry 
Adenovirus receptors 
In order for adenoviruses to begin infecting a target cell, the virion must be 
endocytosed. To do this, two interactions must occur between the viral capsid and host 
cell receptors. The first interaction occurs via a high-affinity interaction between the knob 
domain of the Ad fiber protein and a subgroup-dependent primary attachment receptor on 
the host cell [233, 234]. Ad subgroups A, C, D, E, and F primarily use the Coxsackievirus 
B and Adenovirus Receptor (CAR) to mediate cell attachment [235, 236]. In addition to 
CAR, subgroups C and D can utilize other cell surface receptors as well, depending on 
the cell type. Subgroup C viruses have been suggested to use heparin sulfate 
proteoglycans (HSPG), MHC class I, and VCAM-I as interacting ligands via a basic 
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KKTK motif present within their fiber proteins, and subgroup D can use sialic acid 
and/or CD46 [236-243]. Subgroup B viruses do not appear to use CAR, and instead 
interact with CD46, HSPG, CD80/86, and Demsoglein 2 for their initial binding [244-
246].  
More recently, studies suggest that viral capsids associating with soluble, 
extracellular cofactors aid in primary attachment during systemic infections [247-250]. 
Specifically, the failed use of subgroup C virus Ad5 in a gene therapy study revealed that 
this virus has a CAR-independent tropism for liver cells, instead utilizing various blood 
coagulation factors including Factors VII, IX, and X, as well as the complement 
component C4-binding protein to mediate transduction into hepatic cells [249].  
 Once the Ad fiber has successfully mediated attachment to cells through primary 
receptor interactions, a second, lower-affinity interaction between an Arginine-Glycine-
Aspartate (RGD) motif found within the Ad penton base and Vβ3 or Vβ5 integrins 
induces cell internalization of the virus. Integrin binding induces a cell signaling cascade 
through phosphoinositide-3 kinase and Rho GTPase activation, initiating virion uptake 
through clathrin-mediated endocytosis [251-255]. Observations indicate that the 
interactions between these viral proteins and different receptors mediates virion 
trafficking in the cell to certain compartments [248, 256]. Subgroup C viruses, including 
Ad5, only traffic through early endosomal compartments before penetrating into the 
cytosol [256], where subgroup B viruses must traffic to late endosomes/lysosomes before 
escaping from these vesicles [248, 257]. Studies also suggest that Ad2 (subgroup C) 
interactions with v integrins mediates macropinocytosis in a clathrin-independent 
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process, alongside clathrin-mediated endocytosis [258]. Other reports show that that this 
may be an important mechanism of entry for certain adenovirus species, as inhibitors of 
macropinocytosis prevent the entry of the subgroup B virus Ad3 into cells. Furthermore, 
Ad3 interactions with v integrins, along with CD46, stimulates plasma membrane 
ruffling of the host cell, facilitating increased fluid uptake [259]. 
Adenovirus uncoating and endocytosis 
 Once Ad penton engages integrins and endocytosis has begun, the viral capsid 
must partially dissociate for infection to proceed. Fiber-bound CAR receptors have fluid 
movements within lipid membranes, but penton base-integrin interactions are more rigid 
and spatially confined [260]. These movements induce mechanical stress to the viral 
capsid: Ad fiber is pulled by the drifts in CAR and shed at the cell membrane, 
independent of the initiation of endocytosis [260, 261]. 
 Ad internalization initiates further disassembly of the capsid in a stepwise manner 
[262]. Although initial studies indicated that H+ influx into endosomes to acidify the 
vesicle compartment initiates capsid uncoating for certain serotypes (especially those that 
traffic to late endosomes) [262-265], more recent observations indicate that many 
serotypes, including Ad5 and other subgroup C Ads, do not depend on acidification 
[256]. Ad5 escape from endosomes occurs within 15 minutes of internalization, 
signifying escape from early endosomal compartments, before the virus would encounter 
low pH [191, 206, 256, 262, 266]. Furthermore, adding weak bases to viral infections, 
such as ammonium chloride, does not affect capsid disassembly of subgroup C viruses 
[267]. 
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Adenovirus membrane rupture 
 After Ad is internalized by endosomes and begins the process of uncoating, the 
virus must penetrate into the cytosol to continue the infection process. The virus needs to 
lyse endosomal membranes to achieve this. Initial studies linked the role of viral 
uncoating and endosomal rupture using a temperature-sensitive mutant of the subgroup C 
virus Ad 2 (ts1-39), which cannot uncoat when passaged at the non-permissive 
temperature (39°C), due to hyper-stabilization of the capsid [189, 268]. This virus 
contains a point mutation in the L3-23K viral protease (P137L) that fails to properly fold 
at the non-permissive temperature, and is not properly packaged into nascent virions 
[189, 190, 269, 270]. The protease functions within completely assembled virions to 
cleave six Ad capsid pre-proteins into their mature forms [271-273]. Immature, 
uncleaved virions have increased capsid stability, causing a defect in viral uncoating, 
membrane rupture, and endosomal escape [272]. Ts1-39 virus is either recycled through 
the endocytic network back to the cell surface, or traffics to late endosomes/lysosomes 
and is degraded [191, 256]. 
 More recent studies have linked capsid disassembly to endosomal lysis. 
Dismantling of the viral capsid releases the interior capsid protein VI (pVI), which has 
been recently shown to possess all necessary membrane lytic activity for viral rupture of 
the endosome [206, 208, 274]. Release of pVI from the capsid interior is dependent on 
the uncoating process, and pVI can be detected at the cell surface within 5 minutes of 
virus internalization [209]. Antibodies against pVI do not bind intact virions, thus 
detection of pVI at the cell surface further supports that low pH is dispensable for capsid 
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uncoating [209, 260], even indicating that pVI activity occurs prior to the . Infections 
using an Ad5 mutant that can bind integrins without binding CAR (Ad5-RGD4C) links 
pVI exposure to the capsid-receptor interactions at the cell surface. Ad5-RGD4C-infected 
L929 cells, which do not express CAR, revealed less pVI exposure compared to L929 
cells overexpressing CAR, though both cell types endocytosed similar numbers of virions 
[260]. 
 Protein VI is a structural protein, with approximately 342 copies present in the 
capsid [175, 275], and is implicated in a number of functions during the Ad life cycle. 
Mature, cleaved pVI is suggested to localize underneath each hexon trimer within the 
mature virion [174, 204], and is necessary and sufficient to disrupt membranes in vitro, as 
antibody neutralization targeting pVI prevents Ad membrane rupture [206, 208]. Unlike 
other viruses, such as reovirus, which form small pores in endosomal membranes [276, 
277], pVI wholly fragments endosomes, as evidenced by translocation of high molecular 
weight molecules, including 70 kDa dextrans or whole parvoviruses [265, 278]. The 
membrane rupture activity is contained within a small stretch of amino acids at the N-
terminus of the protein, corresponding to residues 36-53 [206, 208], which is predicted to 
be part of an amphipathic alpha helix. This stretch of residues increases the affinity of 
pVI to associate with membranes and induce positive curvature on the membrane, thus 
causing the membrane to fragment. The amphipathic alpha helix, along with 3 other 
alpha helices in the pVI N-terminus, embeds into the membrane in a parallel manner, 
inducing positive membrane curvature stress to fragment lipid vesicles [207, 208]. 
Although recent structure data suggest that pVI structure does not contain an amphipathic 
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alpha helix while associated with the viral capsid [176], this does not preclude a 
conformational change occurring once pVI has been released from the partially 
dissociated capsid. Deletion of this stretch of residues or mutation of conserved 
tryptophan residues limits membrane interactions and reduces fragmentation of 
liposomes in vitro, although a mutant pVI lacking the amphipathic alpha helix still retains 
some lytic activity [206-208]. 
In addition to its importance in membrane rupture, data also implicate that pVI is 
critical for efficient endosomal escape. A mutant adenovirus that has a mutated PPxY 
motif in the C-terminal portion of the protein (called Ad5-M1) does not hamper the 
ability of the virus to fragment endosomes, but restricts Ad infectivity 20-fold. This 
reduction in infectivity corresponds to an increased colocalization of Ad5-M1 with 
ruptured endosomes over the course of infection (Figure 2). How the PPxY motif 
facilitates virion penetration into the cytosol is still under investigation. 
Galectins as markers for vesicle lysis 
 In intracellular bacterial infections, endosomal lysis is evidenced by the 
accumulation of proteins containing sugar-binding moieties, called galectins [279]. 
Galectins are primarily cytosolic proteins, found within the cell in a diffuse manner. N-
linked glycans present at the cell surface, and thus in the luminal side of an endosome, 
are normally inaccessible to the sugar-binding galectins. However, upon vesicle 
fragmentation, galectins aggregate at the sites of injury to bind the N-linked glycans, and 
these can be visualized as discrete puncta using immunofluorescence. During Salmonella 
infection, galectins -3, -8, and-9 are recruited to sites of endosomal rupture by the 
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bacterium. Gal8 knock down by siRNA enhances Salmonella replication [72]. The 
investigators found that knocking down gal8 expression inhibits ubiquitin binding 
proteins NDP52 and p62 from binding ubiquitinated bacteria, thus preventing 
autophagosome formation around the pathogen. The importance of gal3 and gal9 
recruitment to ruptured endosomes was not elucidated, but siRNA knock down of either 
form had no effect on bacterial replication. 
Autophagy activation 
 Very little has been assessed regarding the role of autophagy during adenovirus 
infection, and of those results, its function has only been looked at at very late times post-
infection (after 24 hours), by which time virus trafficking towards the nucleus and 
genome delivery has already occurred [280-283]. The role of autophagy during 
adenovirus entry remains an open field. Data from our lab suggests that the 20-fold 
infectivity defect of Ad5-M1 occurs as a result of an inability to quickly escape 
endosomes, and is subsequently sequestered by autophagosomes and targeted to 
lysosomes for degradation (Figure 3). In vitro ubiquitination experiments suggest that 
pVI-WT is oligo-ubiquitinated with 2x or 3x ubiquitin appendages after release from the 
capsid. However, the same studies performed with pVI-M1 suggest the mutant protein is 
not as extensively ubiquitinated [209]. Although this makes sense as PPxY motifs are 
frequently ubiquitinated in natural cellular processes [284, 285], it suggests that pVI 
ubiquitination is not the key mechanism of capsid targeting to autophagosomes, as is seen 
with appending ubiquitin to bacterial pathogens. However, other data from our lab 
suggest that it is the host proteins recruited to endosomes upon membrane damage that 
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signal autophagy formation. Similar to what is seen during Salmonella infection, we find 
that galectin-8 knock down by siRNA restores mutant Ad5-M1 infectivity to Ad5-WT 
levels. However, whether the other mechanisms of autophagy recruitment seen in 
bacterial infections are also important during adenovirus infection remain unknown. 
Microtubules facilitate viral transport upon entry 
 Nucleus-bound viruses must translocate across relatively large distances through 
the cytosol to get from the cell surface to the nucleus. The cytoplasm is extremely dense, 
and free movement or diffusion through the medium is limited by a number of organelles, 
cytoskeletal components, and other proteins. Studies using fluorescence recovery after 
photobleaching (FRAP) suggest that molecules greater than 20nm in size are essentially 
immobile in the cytoplasm [286, 287]. Adenovirus particles are 90nm in diameter, 
suggesting that movement through the cell cytoplasm by diffusion is not an effective way 
to deliver its viral DNA to the nucleus. To effectively move through the cell, Ads exploit 
the microtubule network already established within the cell. Chemical depolymerization 
of the microtubule network using nocodazole severely restricts Ad infectivity. 
Furthermore, inhibiting the activity of either dynein or kinesin motors through siRNA 
knockdown or antibody injection limits Ad infectivity, suggesting that both motor 
proteins are intimately involved in entry [288, 289]. Although some literature indicates 
the interaction of viral capsid proteins with motor proteins is important for efficient entry, 
the specific contributions of microtubule motors has not been explicitly uncovered. 
Hexon that is exposed to acidified environments reportedly interacts with dynein in in 
vitro experiments [290]. Hexon, fiber, pIIIa, and pIX all bind kinesin in pull down assays 
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[291]. Furthermore, pVI interacts with microtubules in a PPxY-dependent manner, 
however whether this is due to interacting with dynein, kinesin, or some other interaction 
is yet to be revealed [209]. Current data suggest that dynein traffics the virus towards the 
microtubule organizing center (MTOC) near the nucleus, and kinesin appears to play a 
role in nuclear import, once the virus accumulates at the nucleus.  
Adenoviral genome delivery into the nucleus 
 Once the partially uncoated virus has ruptured endosomes and penetrated into the 
cytosol, it must traffic to the nucleus and deliver its genome. Literature indicates that 
virus movement along microtubules is critical for accumulation at the nucleus. The 
nuclear import factor chromosomal region maintenance 1 (CRM1) competes with Ad for 
microtubule interactions, enhancing capsid dissociation at the nucleus to facilitate 
genome import [292]. Impeding CRM1 function increases Ad accumulation at the MTOC 
and spindle poles, and restricts genome delivery by preventing disassembly of the capsid. 
Once free virus is transported to the nucleus, the capsid docks at the nuclear pore 
complex (NPC), presumably through interactions of hexon and the NPC protein Nup214 
[293]. Once docked, kinesin interacts with pIX present on the capsid and Nup358 at the 
NPC. Opposing forces between the Nup358-kinesin-pIX and hexon-Nup214 interactions 
disrupts the NPC and pulls apart the viral capsid, freeing the viral genome from the 
capsid core [291]. Soluble histone H1 proteins associate with conserved acidic residues 
on hexon, and subsequently other nuclear import factors bind and import the viral DNA 
into the nucleus. 
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Virus replication and nascent virion production 
 Once the genome is in the nucleus, DNA transcription and the replication of new 
virions occurs. The pVII-associated viral DNA complex interacts with nuclear factors, 
including TBP-associates factor 1 (TAF-1), remodeling the viral chromatin structure to 
facilitate transcription of initial viral replicating genes [294, 295]. Altering the viral DNA 
is essential for replication, as early gene expression is severely inhibited cells knocked 
down for TAF-1. RNA polymerase II initiating genome transcription, commencing the 
first stage of viral replication. Within hours, replication of host cell DNA ceases, focusing 
only on viral replication. 
 Viral transcription is temporally divided into two phases – early and late – with 
viral DNA replication acting as the dividing event. Early transcripts are responsible for 
changing the host cell environment to optimally generate new virions, restricting intrinsic 
immune responses generated by the host, and enhancing the transcription of late genes 
necessary for Ad replication and capsid assembly. Early transcription is further broken 
into three subsets: immediate-early, early, and intermediate. In the immediate-early stage, 
RNA polymerase II transcribes the viral E1 gene into E1A mRNA. E1A transcripts are 
exported into the cytoplasm via CRM1-dependent activity [296]. Transcript translation 
and subsequent import of E1A product into the nucleus drives the transcription of the 
other early genes E1B, E2, E3, and E4 via the activation of host cell transcription factors 
[297]. E1A also forces the cell to progress into the S phase of the cell cycle, affecting 
host cell gene expression and promoting the transcription of E2 genes, one of the genes 
transcribed during the early stage of transcription. In addition to E1A activity, E1B 
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translation generates two polypeptides, E1B-19K and E1B-55K. The former inhibits 
infected cell death by blocking the apoptosis inducer Bax [298]. The latter protein forms 
an E3-ubiquitin ligase complex with E4ORF6 to target the tumor suppressor p53 and 
components of the MRN complex, a DNA damage repair system, for proteasomal 
degradation [299]. The E1B/E4 complex also controls selective export of late viral 
mRNAs into the cytoplasm for translation [300]. 
 After E1A activates their transcription, mRNA for the early genes E2, E3, and E4 
undergo alternative splicing processes, are translated, and their gene product begin to 
enact their functions. The E2 gene encodes for three molecular components absolutely 
essential for replication: DNA binding protein (DBP), the precursor terminal protein 
(pTP), and viral DNA polymerase (Ad Pol). These proteins, along with host transcription 
factors NFI and Oct-1, enhance the initiation of viral transcription over 100-fold [301]. 
E3 gene products restrict the cell from producing antiviral defenses by retaining MHC 
class I molecules in ER and down-regulating cell surface expression of TNF-related 
apoptosis-inducing ligand (TRAIL), Fas receptor, and epidermal growth factor receptor 
(EGFR). Activation of the E4 gene produces a number of polypeptides from different 
open reading frames (ORFs). E4ORF6 complexes with E1B-55K as described above. 
E4ORF3 targets components of the MRN complex to aggresomes and disrupts 
promyelocytic leukemia (PML) bodies in the nucleus, inhibiting these structures from 
sequestering and restricting viral replication machinery [302, 303]. Deleting E4ORF3 
severely limits adenovirus replication. E4ORF1 binds and activates MYC, enhancing the 
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production of glycolytic enzymes and increasing the biosynthesis of nucleotides [304]. 
E4ORF4 negatively regulates E1A-activated transcription [300]. 
 Once the functions of the early genes predispose the cell for optimal virion 
production, DNA synthesis can commence. The intermediate genes IVa2 and IX are 
transcribed and translated [183, 305, 306]. These viral genes are the only two genes that 
do not produce multiple splice variants, translating only one gene product. The gene 
product of IVa2 is the first virally-expressed protein to contain DNA-binding activity, 
and is restricted to the nucleus after translation. Protein IVa2 dimerizes and binds to 
sequences upstream of the major late promoter (MLP), acting as transcription factor to 
activate the MLP and transcribe late genes L1-L5, which encode capsid structural 
proteins [307]. The function of pIVa2 likely enhances the binding of other proteins to 
viral DNA. In vitro assays indicate it has no transcriptional activity by itself, and it 
requires the assistance of host regulatory factors to stimulate MLP promoter activity. In 
addition to its transcriptional activity, pIVa2 aids in viral DNA packaging into maturing 
capsids [180]. 
 Although the N-terminus of intermediate gene IX product pIX is important for 
capsid incorporation, its C-terminal alanine-rich region and leucine zipper domain acts as 
a trans-activator of both viral and host genes [305, 306]. It is the only viral protein to act 
as both a structural protein and a transcription factor. Although it contains no DNA-
binding activity of its own, it enhances transcription at both viral and cellular promoters 
containing TATA sequences, including the MLP. Vectors deleted for pIX produce less 
fiber capsid protein during the course of infection and cannot incorporate full-length 
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genome into assembling virions compared to pIX-sufficient controls, indicating its 
importance during virion production [308]. Deleted vectors also exhibit a two- to three-
fold decrease in virus production after expansion in complementing cells. Its activity is 
enacted even when expressed in uninfected cells by plasmid transfection, indicating that 
its function occurs in the absence of other viral proteins. In addition to its transcriptional 
activities, the pIX leucine repeat is a critical mediator of PML-body sequestration, 
keeping them from accumulating at sites of viral replication [309]. It may act sequentially 
with E4orf3 to evade PML-stimulated restriction of DNA replication. Levels of pIX 
expression change during the course of replication, starting at low levels at the 
intermediate stage and increasing to higher levels after DNA replication has begun [310]. 
This change in expression levels is inversely proportional with the levels of E1B 
transcription, as the E1B coding sequence reads through both gene IX’s promoter and 
coding sequence [311]. Once E1B transcription subsides after DNA replication begins, 
pIX expression dramatically increases. 
 Simultaneously with intermediate gene expression, Ad Pol, pTP, and DBP act in 
concert to replicate viral DNA, producing up to 106 nascent genomes within 40 hours, for 
both increased transcription and packaging into assembling capsid molecules. The TP-
bound 5’ ends of the DNA encounter a pTP-Ad Pol complex containing a covalently-
bound cytosine molecule to the pTP [312]. Two host transcription factors, nuclear factor I 
(NFI) and nuclear factor III (Oct-1) each independently enhance replication initiation, 
with an additive effect of greater than 100-fold [313]. Late gene mRNA transcripts 
produce the structural capsid proteins necessary for virion assembly, which occurs within 
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the nucleus, where the viral genomes reside. Fiber trimers and penton pentamers mediate 
their own import into the nucleus via encoded nuclear localization signals (NLS). Hexon 
proteins have no NLS in their sequences, and upon trimerization rely on import into the 
nucleus via pre-protein VI [211]. Once all of the capsid proteins are present within the 
nucleus, assembly is initiated. Empty capsids containing all of the outer shell pre-proteins 
and viral protease molecules assemble without DNA present within the capsid, then 
pIVa2 and late gene-encoded scaffolding proteins mediate viral genome insertion into 
capsids. Conflicting evidence muddies the complete understanding of capsid assembly. 
Studies inhibiting DNA import into capsids results in unassembled capsid molecules 
within the nucleus, suggesting capsid assembly is not spontaneous and that there is a 
discrete link between DNA interactions with capsid proteins and capsid assembly [314]. 
Regardless of how these molecules assemble and import viral DNA, once DNA is present 
within the capsid, the viral protease cleaves all pre-proteins into their final forms, 
converting the virion into a mature state, ready for infection. In replication-competent 
adenoviruses, the adenoviral death protein (ADP) induces cell apoptosis, releasing the 
newly-created virions into the extracellular milieu [315].
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CHAPTER II 
 
MATERIALS AND EXPERIMENTAL METHODS 
 
Cell Lines and Viruses. Tissue culture reagents were obtained from Mediatech and 
HyClone. HeLa and A549 cells were purchased from ATCC. 293β5 cells were a kind gift 
from Dr. Glen Nemerow [316]. MEFs were a kind gift from Dr. Ed Campbell. HeLa cells 
stably over-expressing KLC1 TPR or HA-tagged pIX sequences were created by 
transfecting 293β5 cells with retroviral EXN vectors (Cherry-C1AJ or EXN vectors, 
respectively) containing the sequence of interest along with pCig and HEF-VSVg 
packaging plasmids. Retrovirus produced and isolated from these cells were then used to 
transduce HeLa cells by spinoculation and incubation for 5 hours. Cells were rested for 
48 hours, then selected for transgene integration with G418 sulfate solution (MP 
Biochemicals). Stable HeLa cells were maintained in G418 and assessed for stable 
integration by immunoblot. HeLa, 293β5, A549, and stable HeLa cells were maintained 
in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS), 100 IU/ml penicillin, 1 mg/ml streptomycin, 0.25 μg/ml amphotericin B, 
non-essential amino acids, 1 mM sodium pyruvate, 10 mM HEPES buffer and 2 mM 
glutamine. The Ad5-WTgfp and Ad5-M1gfp viruses were previously described [209]. 
Ad5-WTluc was generated by recombination using Ad5-WT in a BAC and the pShuttle-
LucCP vector. Ad5-ΔpIXgfp virus was generated by recombination using Ad5-WT 
backbone in a BAC and the pShuttle-CMV eGFP vector digested with MfeI and re-
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ligated to remove the pIX coding sequence. All viruses were propagated in 293β5 cells 
and purified from cellular lysates by double banding in cesium chloride gradients and 
dialyzed in 40 mM Tris, 150 mM NaCl, 10% glycerol, and 1 mM MgCl2 (pH 8.2) [206]. 
Viral concentrations were determined by Bradford assay (Bio-Rad Laboratories, Inc.) and 
aliquots were flash frozen in liquid nitrogen and stored at –80°C. 
Reagents, siRNAs, and Antibodies. Bx795 was purchased from InvivoGen. Nocodazole 
(NOC) and DMSO were purchased from Sigma-Aldrich. Dorsomorphin and STO-609 
were purchased from Cayman Chemicals. SB202190 and JNK inhibitor I-II were 
obtained from Calbiochem. Ciliobrevin D was purchased from EMD Millipore. NOD1 
and NOD2 siRNAs were obtained from Dharmacon. Control siRNA was purchased from 
Cell Signaling. DLC1 and BAG3 siRNAs were purchased from Santa Cruz 
Biotechnology KLC1 siRNA was kindly provided by Ed Campbell. The following 
primary antibodies were used: rabbit LC3, mouse β-actin (Sigma-Aldrich), mouse 
galectin-3 (BD Biotechnology), and rabbit CD107a (LAMP-1, Thermo Scientific). 
Biotin substrate 
Infectivity Assays: Cells were plated in 24 well plates to yield 0.5-1x105 cells/well the 
day of infection. Cells were collected 18-24 hours after infection, pelleted, and 
resuspended in buffer (PBS with 1% FBS + 0.1% sodium azide) and GFP+ cells were 
counted via flow cytometry (Accuri or Canto). 
For drug-treated cells, cells were pretreated for with the specified concentrations 
of drug for 30 minutes:  Bx795, 2.5, 5, 7.5, or 10 μM; Nocodazole, 30μM; Ciliobrevin D, 
50μM; Dorsomorphin, 40 μM; STO-609, 1 μg/ml; JNK I-II, 10 μM; and SB202190, 20 
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μM. After pretreating, cells were infected in the presence of drug for one hour, then 
washed and treated with drug for two more hours, at the same concentrations. Cells were 
washed three times with PBS and fed media without drug for overnight incubation. 
For Ad12 pre-existing immunity assays, cells were transduced with Ad5gfp (20 
ppc) or Ad12 (50,000 ppc) overnight in the presence of cord blood diluted in DMEM to 
1:16 the original concentration. The next day, cells were washed, fixed with 10% 
paraformaldehyde in 0.159M PIPES (Sigma) solution for 10 minutes, blocked and 
permeablized with 10% FBS and 0.5% saponin (Sigma) PBS solution for one hour, and 
stained to detect infected cells. Ad12-infected cells were stained with rabbit Ad12 
antisera and 488-conjugated goat anti-rabbit secondary antibody (Life Technologies). 
Cells transduced with Ad5gfp were mock-stained. All cells were incubated with DAPI to 
label cell nuclei. Fluorescence was assessed and imaged by standard fluorescent 
microscopy, and the percentage of infected cells were quantified by hand using ImageJ. 
siRNA Knockdown: HeLa cells were plated in 24 well plates and transfected with each 
siRNA using Lipofectamine 2000 (Invitrogen). Cells were transfected with 20 pmol (Day 
1) and with 30 pmol (Day 2) with each siRNA per well. Cells were infected seventy-two 
hours after the first transfection. 
Immunofluorescence Microscopy: A total of 3.5x104 cells were plated on glass 
coverslips. The next day, cells were chilled on ice for 30 minutes and infected with 
fluorescently-labeled 3x104 vp/cell on ice for 1 hour. After virus binding, cells were 
washed three times with ice-cold PBS, then shifted to 37°C with pre-warmed medium to 
allow for virus internalization. At different times post-virus internalization, the cells were 
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washed with PBS and fixed with 4% paraformaldehyde (Electron Microscopy Sciences) 
in 0.159M PIPES buffer (Sigma) for 10 min. After all time points were fixed, cells were 
blocked ad permeablized for 1 hr in PBS with 10% FBS and 0.5% saponin (Sigma). 
Staining with specific mono- or polyclonal antibodies was performed in 10% FBS with 
0.5% saponin for 1 hr. Secondary Alexa Fluor 568-conjugated (Invitrogen) and DyLight 
649-conjugated (Jackson) antibodies were used. Viruses were pre-labeled with Dylight 
488 NHS-Ester Fluorophores (Thermo Scientific), according to the manufacturer's 
protocol prior to use. DAPI was used to counterstain nuclei before coverslips were 
mounted on glass slides with Fluoro-Gel (Electron Microscopy Sciences). Z-stack images 
were acquired using identical parameters for each time point with a DeltaVision 
microscope (Applied Precision) using a CoolSnap HQ digital camera (Photometrics) with 
a 1.4-numerical aperture (NA) 100× objective lens, and deconvolved with SoftWorx 
deconvolution software (Applied Precision). Images were assembled using IMARIS and 
ImageJ softwares. Virus particles, LC3 puncta and galectin puncta three-dimensional 
surfaces were acquired using IMARIS software. Colocalization was determined by the 
fluorescence intensity of the protein of interest at each three-dimensional surface 
compared to the fluorescence intensity of the secondary only control. 
Pull Down: 10-cm dishes seeded to a final total of ~5x106 HeLa or 293β5 cells were 
lysed in a solution of PBS containing 0.1% Triton X-100 and 1mM PMSF for 10 minutes 
at 4°C. Cells were scraped into a 1.5mL eppendorf, and cell debris pelleted. Supernatant 
was collected and incubated with NHS-Biotin (final concentration 0.3 mg/ml), 1 hour at 
4°C. Simultaneously, 150μg his-tagged pVI or GFP, or a 10% FBS solution alone, was 
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incubated with 20μl of a 50% cobalt bead resin slurry. Afterwards, the biotinylation 
reaction was quenched with 40mM glycine (pH 7.5), for 30 minutes at 4°C, and cobalt 
beads were pelleted at 2000 RPM (1 minute) and washed twice with PBS. Once 
quenched, lysates were pre-cleared with FBS-incubated cobalt beads plus 10mM 
imidazole, 1 hour. Preclearing beads were pelleted at 2000 RPM, and supernatant 
decanted into eppendorfs containing pVI- or GFP-loaded cobalt beads. Lysates incubated 
at 4°C, 1 hour, then cobalt beads were pelleted and washed twice with PBS, then eluted 
with 20μl of PBS containing 20, 50, and 500mM imidazole. Bead pellets were 
resuspended in 20μl of a solution containing 25mM Tris, 25mM NaCl, 0.1mM EDTA, 
1% Triton X-100, 0.5% NaDeoxycholate, and 0.1% β-mercaptoethanol. 6x denaturing gel 
loading dye was added to eluates and beads (to 1x concentration), boiled at 100°C for 5 
minutes, pelleted at max speed, and subject to immunoblotting (see below). Blots were 
probed with streptavidin-HRP solution, 1 hour at room temperature.  
Immunoblotting: Cells were lysed in a solution containing 25mM Tris, 25mM NaCl, 
0.1mM EDTA, 1% Triton X-100, 0.5% NaDeoxycholate, 0.1% β-mercaptoethanol and 
1mM PMSF, run on 15% SDS-PAGE gels, and transferred to nitrocellulose membranes 
(Bio-Rad). Membranes were probed either at 4°C overnight or at room temperature for 1-
2 hours in TBST 0.1% with 5% BSA or PBST 0.05% with 5% milk. Mouse and rabbit 
HRP-conjugated secondary antibodies were used (Thermo Scientific). Membranes were 
developed with Dura substrate (Thermo Scientific) on GE or Denville film, or using a 
digital imager.  
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Statistical Analysis: Statistical significance (p < 0.05) was assessed using the Student's t-
test whenever two groups were compared. Data are presented as mean ± SEM. 
Calculations were performed with Microsoft Excel (Microsoft, Inc.) or GraphPad Prism 
software (GraphPad Software, Inc.).
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CHAPTER III 
 
RESULTS 
 
Host autophagic components induced to restrict adenovirus upon endosomal 
rupture 
Ad-induced membrane rupture recruits LC3 to sites of injury  
 Virus induction of autophagy and its effects on replication has been documented 
for a number of viruses [317-323]. Some of these viruses, such as poliovirus, exploit 
autophagosome formation to their advantage during replication [318]. Others, like HSV, 
use virally-encoded proteins to evade autophagic restriction [321]. Studies of autophagy 
induction in Ad infections is limited to late times in infection, after viral entry and 
genome delivery occurs, and replication is underway [280, 281, 283]. In these reports, 
western blot assessment of LC3 cleavage into its lipidated form (LC3-II) suggested Ad-
induced autophagy generally occurs at 24 hours post-infect (hpi), and the earliest 
observed formation of autophagosomes happens at 12 hours post-infection (hpi), based 
on LC3 cleavage-dependent luciferase secretion assays [283]. However, the earliest time 
point looked at in these studies was 6 hpi, still well after Ad entry occurs. Furthermore, 
autophagy incorporation of LC3-II will inevitably turnover the protein upon fusion with 
lysosomes, thus any LC3 cleaved earlier than 6 hpi is likely degraded prior to the 6 hour 
readout. Therefore, we sought to assess whether Ad entry stimulates autophagy induction 
during entry, within 2 hpi. 
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 Human adenovirus 5 (Ad5) with a mutant PPxY motif (Ad5-M1 PPSY to PGAA) 
in the membrane lytic protein VI (pVI) is ~20-fold defective in infectivity compared to 
Ad5-WT. Previous data indicate that the mutant retains the capacity to rupture 
endosomes, as assessed in vitro [209], as well as by its ability to induce gal3 punctate 
staining in immunofluorescence assays (IFA) during infection [210]. However, Ad5-M1 
does not efficiently traffic to and accumulate at the perinuclear region of the cell. These 
observations suggest that this mutant virus’s defect lies downstream of uptake and 
endosomal rupture, but upstream of viral trafficking through the cell cytoplasm. As 
previous literature indicates that Salmonella-mediated vesicle fragmentation induces 
bacterial sequestration by autophagosomes [72], we hypothesized that Ad does stimulate 
autophagy upon entry, and that the Ad5-M1 defect is due to enhanced uptake by 
autophagosomes. 
AlexaFluor-488 fluorescently-labeled Ad5-WT or Ad5-M1 virions were 
incubated with 4°C-chilled HeLa cells on ice to allow virus to bind, but not endocytose 
into, cells. Once bound, cells were washed with PBS to remove unbound virus, and 37°C 
pre-warmed media was added to cells to induce synchronous infection. Cells were fixed 
and stained over a time course to determine whether LC3 is recruited to sites of 
endosomal rupture. Fixed cells were stained with antibodies against gal3 and LC3 to label 
ruptured endosomes and autophagosomes, respectively. We found that LC3 is recruited 
to lysed vesicles within 30 minutes post-temperature shift, and LC3 cleavage during 
infection was confirmed by western blot (Figure 1A). Both Ad5-WT and Ad5-M1 viruses 
induce similar numbers of LC3 puncta in cells, but cells transduced with mutant ts1 Ad 
  
55 
that do not rupture endosomes do not induce LC3 punctate staining above background in 
non-transduced cells. These data suggest that Ad-mediated recruitment of 
autophagosomes requires membrane rupture (Figure 1B) [324]. 
The pVI PPxY motif enhances Ad evasion of host restriction by autophagy 
 Although Ad5-WT and Ad5-M1 both induce autophagy, they may not be affected 
by this host restriction process if they escape from sequestration. It is not known whether 
these viruses escape from sites of membrane rupture prior to autophagosomal isolation. 
Since Ad5-M1 is defective for gene delivery, it is conceivable that Ad5-WT, but not 
Ad5-M1, penetrates into the cytosol in a time-efficient manner, thus evading restriction 
by autophagosomes. To test this, we assessed whether Ad5-WT efficiently egresses from 
endosomes prior to LC3 accumulation, compared to Ad5-M1. Using the same time 
course model described above, we calculated the percent of 488-labeled virus colocalized 
with LC3. We found that Ad5-M1 is more highly colocalized with LC3 accumulations 
compared to its WT counterpart when transduced with similar numbers of physical 
particles per cell, in accordance with our hypothesis (Figure 1C) [324]. 
The fate of autophagosomal contents is typically degradation after phagophore 
fusion with lysosomes. However, some pathogens mediate infection by preventing this 
fusion event. We hypothesized that since Ad5-WT simply evades the initial sequestration 
event, Ad5-M1 is likely targeted to lysosomes for destruction. We performed a time 
course to assess virus colocalization with the lysosomal marker LAMP1. We found that, 
compared to Ad5-WT, Ad5-M1 is significantly more associated with LAMP1-positive 
membranes, suggesting that the mutant virus is more efficiently targeted to degradative 
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Figure 1: Effects of autophagy in Ad restriction during entry. HeLa cells infected 
with AlexaFluor 488-labeled Ad5-WT or Ad5-M1 virus were either lysed or fixed. A. 
Western blot of whole cell lysates probed for LC3. B. Quantification of the number of 
LC3 puncta per cell. C. LC3 puncta colocalized with Ad5. D. Ad5 colocalization with 
LAMP1. *p<0.05, **p<0.001 
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lysosomes after appropriation by autophagosomes (Figure 1D). Taken together, these 
data indicate that Ad-induced membrane damage mediates LC3 conscription to damaged 
vesicles, and the pVI-PPxY motif is critical for the virus to efficiently abscond from these 
sites to evade phagophore sequestration. The concomitant destruction of autophagosomal 
contents by lysosomes is the mechanism by which the cell restricts viral particles unable 
to escape from ruptured endosomes. This correlates with previous findings that viral 
genomes are quickly degraded after entry in Ad5-M1 transductions, but not for Ad5-WT 
[325]. Additionally, knocking down components of the autophagy expansion process 
restores Ad5-M1 infectivity to wild-type levels, further demonstrating that autophagy is a 
critical mechanism employed by the cell to restrict incoming viruses upon exposure to the 
cytoplasm [324]. 
TBK1 activity recruits LC3 to Ad-ruptured endosomes 
The previous results show that LC3 is recruited to Ad5-ruptured endosomes and 
that autophagy restricts Ad5-M1 infection, however these experiments do not reveal 
mechanism of autophagy activation by Ad cell entry. We sought to determine the host 
molecules involved in activating autophagy and completing phagophore formation. Other 
data demonstrate that during infection with intracellular bacterial pathogens, such as 
Salmonella and Shigella, membrane rupture promotes cell-mediated ubiquitination of the 
pathogens, which is important to efficiently target autophagy machinery to sites of 
damage [76, 85]. Pathogen ubiquitination facilitates the conscription of ubiquitin-binding 
adaptor proteins p62, NDP52, and optineurin (OPTN) to sites of vesicle fragmentation 
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during infection [81, 82, 326]. NDP52, p62, and OPTN in turn are part of a danger 
signaling pathway to target cargo for degradation via autophagy. 
In vitro biochemical analyses suggest that pVI is ubiquitinated by host Ub ligases 
in a PPxY-dependent manner [209]. We asked whether the PPxY motif mediates 
ubiquitin targeting to sites of membrane rupture in the context of infection. Preliminary 
IFA studies suggest that both Ad5-WT and Ad5-M1 induce similar numbers of ubiquitin 
puncta upon rupture (Figure 2). Additionally, there is no difference in the percent of 
virions colocalized with ubiquitin with either virus, suggesting that the pVI-PPxY motif 
does not specifically mediate ubiquitin targeting to sites of membrane damage. This 
result is in agreement with previous reports indicating that membrane rupture mediated 
by transfecting cells with latex beads is sufficient to conjugate ubiquitin to host proteins 
[77]. However, our IFA data do not specify whether the virion itself or host proteins are 
ubiquitinated. Taking our findings with the in vitro data previously described, perhaps the 
PPxY motif is important to properly ubiquitinate pVI, but has no effect on the 
ubiquitination status of neighboring host proteins. 
Next, we assessed whether ubiquitination at sites of rupture recruits ubiquitin-
binding adaptor molecules in a pVI-PPxY-dependent manner. IFA assessment of p62 and 
NDP52 location within the cell shows that Ad infection induces an accumulation of these 
proteins during entry, and Ad5-M1 colocalizes with them significantly more than Ad5-
WT, with kinetics similar to those seen with gal3 colocalization (Figure 3) [324]. These 
results indicate that, akin to what is seen during bacterial-induced membrane rupture, p62 
and NDP52 recruitment occur upon endosomal disruption by Ad.  
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Figure 2: Ad5 colocalization with ubiquitin. HeLa cells infected with AlexaFluor 488-
labeled Ad5-WT or Ad5-M1 virus (green) were fixed and stained for ubiquitin (red) one 
hour post-entry. A. Representative micrographs of Ad5-WT, Ad5-M1, or uninfected 
cells. Virus (green). B. Quantification of the number of ubiquitin puncta per cell at one 
hour post-infection. C. Percent of virus colocalized with ubiquitin puncta. 
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Figure 3:  Ad5 colocalization with adaptor proteins p62 and NDP52. HeLa cells 
infected with Ad5-WT or Ad5-M1 (green) were fixed and stained for p62 or NDP52 
(red). A. Representative micrographs from 30 minutes post-infection. Bar is 5μm. B. Ad5 
colocalization with p62. C. Ad5 colocalization with NDP52. *p<0.05, **p<0.001 
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Once NDP52 binds ubiquitinated Salmonella after membrane damage, the adaptor 
molecule complexes with the protein kinase TANK-binding kinase-1 (TBK1), which in 
turn phosphorylates NDP52, p62, and OPTN molecules bound to ubiquitin to label them 
and their bound targets as autophagic cargo [81, 82, 326]. Phosphorylation by TBK1 
increases the affinity of these adaptors for LC3, which is involved in elongation of the 
autophagic phagophore. We next asked whether TBK1 activity is similarly important in 
restricting Ad infection during entry. A reversible chemical inhibitor of TBK1, Bx795, 
acts as an ATP competitive inhibitor to impede TBK1’s phosphorylating kinase activity 
[327]. Bx795 prevents OPTN phosphorylation, which is necessary for restricting 
Salmonella activity [81]. 
To test whether a similar occurrence happens during Ad infection, we pre-treated 
cells with various amounts of Bx795, ranging from 2.5μM to 7.5μM, or vehicle control 
(0.1% DMSO) for 30 minutes. Cells were transduced with replication-defective Ad5-WT 
or Ad5-M1 viruses containing a CMV-driven GFP transgene in the presence of the same 
concentration of drug during pre-treatment (Ad5-WTgfp and Ad5-M1gfp, respectively), 
for two hours. Finally, cells were washed three times and treated for one more hour with 
drug or vehicle before being washed three times with PBS and fed complete medium 
without drug. Cells were incubated overnight, between 18-24 hours to ensure genome 
delivery, and GFP expression was assessed by flow cytometry. We found that inhibiting 
TBK1 phosphorylation activity with Bx795 enhances Ad5-M1 infectivity in a dose-
dependent manner in transduction assays (Figure 4A). These results suggest to us that one 
or more adaptor molecules is necessary for efficient restriction of Ad5-M1 infection. 
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Figure 4: TBK1 activity in autophagosomal restriction of Ad5. A. HeLa cells treated 
with varying doses of Bx795 were transduced with Ad5-WT or Ad5-M1. Specific 
infectivity (particles per GFP-transuding unit, or GTU) is calculated as the number of 
viral particles added to a well divided by the total GFP-positive cells in the well. B. 
Whole cell lysates infected with Ad5 in the presence of 0, 5, or 10μM Bx795 were 
probed for LC3 cleavage by western blot. Uninfected and rapamycin lanes serve as 
positive and negative controls, respectively. C. Representative micrographs of HeLa cells 
infected with 488-labeled Ad5-M1 (green) and stained for LC3 (red) in the presence or 
absence of 10μM Bx795 one hour post-infection. D. LC3 puncta colocalized with virus. 
E. Percent of Ad5 colocalized with galectin-3. *p<0.05, **p<0.001 
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Previous reports indicate that Bx795 treatment has no effect on starvation-induced 
LC3 cleavage in MEFs, so we hypothesized that Bx795 would have no effect on LC3 
cleavage in our assay [83]. Cells were synchronously infected with either Ad5-WT or 
Ad5-M1 in the presence or absence of 10μM Bx795. Thirty minutes post-warming, cells 
were trypsinized, lysed, and subjected to western blot procedures. Cleavage and 
lipidation of LC3-I results in a lower molecular weight band when probed with anti-LC3 
antibodies (LC3-II). Thus, lysates were probed for LC3, and the amount of LC3-I 
converted to LC3-II was assessed by densitometry as a percentage of total LC3. Contrary 
to our expectations, we found that treating cells with Bx795 diminishes the amount of 
LC3-II formed during infection (Figure 4B) compared to DMSO-treated transduced and 
rapamycin controls. In fact, 10μM Bx785 treatment reduces LC3 cleavage to background 
levels. Although this result is surprising, it implies that in HeLa cells, TBK1 activity is 
important for LC3 cleavage during viral transduction, further confirming its importance 
in restriction during Ad entry. 
Since Ad5-M1 infectivity is enhanced when cells are treated with Bx795, and 
LC3 cleavage is reduced, it stands to reason that Ad5-M1 would not associate with LC3 
during the course of infection. However, even in the absence of LC3, the mutant virus 
should still be defective in timely endosomal escape. Thus, we hypothesized that cells 
infected with Ad5-M1 in the presence of Bx795 will lead to a reduction in virus 
colocalization with LC3, but virus should remain associated with ruptured endosomes at 
late times during entry. To test this, IFA was performed on cells pre-treated with 10μM 
Bx795 or 0.1% DMSO. Cells were transduced with 488-labeled Ad5-WT in DMSO or 
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Ad5-M1 in either DMSO or Bx795, and fixed two hours post-warming. Fixed cells were 
stained for gal3 and LC3, and colocalization assessed. We found that at 1 hour post-
infection, Ad5-M1 virus in cells treated with Bx795 associates with autophagosomes 
significantly less often compared to vehicle control treated, compared to vehicle-control 
transduced cells (Figure 4D). Ad5-M1 colocalization with gal3 is not statistically 
significantly different between Bx795 treatment and DMSO controls (Figure 4E). These 
data indicate that, similar to the responses induced during intracellular bacterial 
infections, autophagy induction during endosomal rupture by Ads requires TBK1 activity 
to expand and complete autophagosomes formation to sequester endosome-associated 
contents. Furthermore, Ad5-M1’s inability to escape restriction by autophagy occurs due 
to an inability to egress away from endosomal fragments before autophagosomal uptake. 
Autophagy signaling pathways assessed during Ad infection 
To this point, we have assessed the mechanisms of autophagic restriction of Ad 
during entry. However, we have not examined the method of autophagy induction after 
endosomal lysis. Much interest lies in how autophagy is induced and subsequently 
recruited to Ad-ruptured endosomes, for both developing treatments against Ad infection 
as well as designing improved Ad vectors for vaccine development. Our lab previously 
showed that knocking down gal8 with siRNA enhances Ad5-M1 infectivity to Ad5-WT 
levels, corresponding to reduced Ad5-M1 colocalization with LC3-positive 
autophagosomes. However, autophagosome formation is still induced to similar levels 
when compared to control siRNA cells.  These results implicate that membrane rupture 
alone is sufficient to induce autophagy, but the cell cannot properly target 
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autophagosomes to sites of injury in the absence of gal8. To this end, we sought to 
determine the pathway by which Ad entry induces autophagy. 
Many pathways feed into autophagosome formation, each involving various 
signaling components (Figure 5). Data from the laboratory of Harald Wodrich at the 
University of Bordeaux suggest that, while the canonical pathway of autophagy 
activation through mTOR inhibition is regulated by Ad during infection, mTOR’s 
function is dispensable regarding host restriction of Ad5-M1 in U2OS cells (personal 
communication). We also assessed some of the pathways that feed into autophagy 
activation through the mTOR pathway. We used inhibitors of upstream signaling 
molecules of mTOR, 5’ AMP-activated protein kinase (AMPK, dorsomorphin) and 
calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2, STO-609), to assess 
whether they are important for restricting Ad through autophagy during infection. 
Signaling through either of these molecules activates autophagy by inhibiting mTOR 
function, so if mTOR inactivation via AMPK or CaMKK2 is important to restrict Ad 
infectivity, then treating cells with these inhibitors should restore Ad5-M1 infectivity to 
WT levels. We observed little change in the specific infectivities of either Ad5-M1gfp or 
Ad5-WTgfp when treated with these inhibitors (Figure 6), corroborating the evidence 
from Dr. Wodrich’s lab. Taken together, these data would suggest that autophagy 
induction occurs in an mTOR-independent pathway. 
We previously reported that Ad-induced membrane damage mediates the 
production of high levels of reactive oxygen species (ROS) [31, 329]. ROS acts as an 
immune signal of infection and cell stress to activate the NLRP3 inflammasome, and 
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Figure 5: Signaling pathways mediating autophagy regulation. Adapted from [328]. 
Multiple signaling cascades, including mTOR-dependent and –independent pathways, 
have a described capacity to induce autophagosome formation via initiation by unique 
stimuli. 
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Figure 6: AMPK signaling during Ad5 entry. HeLa cells were transduced with Ad5-
WT or Ad5-M1 in the presence of 0.1% DMSO vehicle, 1μg/ml STO-609 (A), or 40μM 
dorsomorphin (B). Results displayed as infectivity relative to vehicle control set to 100%. 
**p<0.001 
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augments TLR9-dependent cytokine expression. In addition to this role, others have 
demonstrated a complex role for ROS in signaling the induction of autophagy [330-332]. 
These reports, in addition to our observations that membrane rupture induces both ROS 
and autophagosome formation, suggest that ROS produced upon Ad transduction may 
signal autophagy induction. 
Our lab previously showed that siRNA knockdown of beclin-1 partially restores 
Ad5-M1 infectivity. ROS signaling feeds into beclin-1 activation, which is mediated by 
JNK1 and ERK1/2 activation. ROS activates JNK1 and ERK1/2, which both indirectly 
activate beclin-1 by inhibiting Bcl-2, a beclin-1 inhibitor. Unpublished results from our 
lab suggest that chemical inhibition of ERK using PD90859 has little effect on general 
Ad5 infectivity (data not shown). Similarly, we chemically inhibited JNK1 to test 
whether this pathway is involved in restricting Ad5-M1 infectivity. In our hands, 
inhibiting JNK1 with JNK inhibitor I-II results in insignificant decreases in the 
infectivities of both Ad5-WTgfp and Ad5-M1gfp (Figure 7A), suggesting that beclin-1-
facilitated autophagy induction is not mediated by these molecules during Ad entry. Very 
recently, p38 mitogen-activated kinase (p38 MAPK, or p38) was observed to activate 
autophagy in CD8+ cells in an mTOR-independent pathway [333]. Others have shown 
that p38 function is important in mediating ROS-dependent activation of autophagy-
related genes [334]. Although limited reports suggest that IFNγ-induced autophagy is 
mediated by p38 signaling [335, 336], no one to our knowledge has assessed whether 
membrane damage activates autophagy via p38 signaling. We tested whether this is the 
case during Ad infection using a potent and specific inhibitor of p38, SB202190, in 
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Figure 7: ROS-dependent beclin-1 activation in Ad5 infection. HeLa cells were 
transduced with Ad5-WT or Ad5-M1 in the presence of 0.1% DMSO vehicle, 10μM JNK 
I-II (A), or 20μM SB202190 (B). Results displayed as infectivity relative to vehicle 
control set to 100%. 
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transduction assays with Ad5-WTgfp and Ad5-M1gfp. However, we found that the 
inhibitor has little effect on viral infectivity for either virus, suggesting that p38-
dependent activation of autophagy is not responsible for induction by Ad entry (Figure 
7B). 
Nod1 and Nod2 receptors have a role in restricting bacterial infection by 
recruiting autophagy proteins to the site of entry [70, 337]. Furthermore, Nod2-dependent 
responses were previously observed to contribute to proinflammatory responses against 
helper-dependent adenoviral vectors in a MyD88-independent manner [338]. We 
assessed whether either of these proteins are important in Ad induction of autophagy. 
Using siRNA to knock down each protein, we assessed the infectivity of Ad5-WTgfp and 
Ad5-M1gfp viruses compared to control siRNA cells. We found that knocking down 
Nod2 has no effect on virus infectivity, however knocking down Nod1 significantly 
increases the percent of GFP-positive cells for both viruses (Figure 8). These data suggest 
that Nod1, but not Nod2, is important in restricting Ad infection, but in a pVI-PPxY-
independent manner. This is in agreement with previously published results. However, 
we did not further assess Nod1’s function in Ad entry. 
Taken together, we show that autophagy is a major factor in restricting Ad5-M1 
infection during viral entry. Recruitment of ubiquitin-LC3 adaptor molecules and their 
phosphorylation by TBK1 is critical to sequester and limit the mutant virus. We also 
found that the JNK1 activity may have a role in efficient Ad infection, but occurs in a 
pVI-PPxY-independent manner. A recent report indicates that in airway epithelial cells, 
starvation-induced autophagy aids Ad infection [339]; perhaps initiation of the 
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autophagic machinery involving this pathway is important to recruit some host factor or 
factors necessary for Ad endosomal escape or trafficking through the cytosol. On the 
other hand, siRNA knockdown of Nod1 increases infectivity of both viruses, suggesting 
that Nod1 plays an uncharacterized role in restricting Ad entry. How this occurs, and how 
autophagy is induced and restricts Ad in a pVI-PPxY-dependent manner, still requires 
testing. 
Contributions of dynein motor function during Ad entry 
As suggested above, Ad must evade autophagy to efficiently infect cells. To do 
so, we hypothesize that Ad egresses from endosomes, penetrating into the cytosol and 
away from the autophagy machinery. The current body of literature suggests that viral 
trafficking throughout the cell requires transport on microtubules, utilizing the 
microtubule motors dynein and kinesin. We therefore asked whether one or both of these 
motor proteins is important in facilitating Ad evasion of autophagy. 
During the initial viral uncoating process, pVI releases from the capsid and 
ruptures endosomes, exposing the virion to the cytoplasm [206, 208, 210]. Once the virus 
has escaped into the cytosol, pVI does not leave with the capsid, but remains associated 
with the endosomal fragments. Depolymerizing microtubules using nocodazole 
significantly restricts Ad5-WT infectivity, but has no effect of Ad5-M1, suggesting that a 
failure of pVI to associate with microtubules, either directly or indirectly, causes the 
mutant virus’ defect. Wodrich, et al. found that transient overexpression of RFP-tagged 
pVI-WT highly colocalizes with tubulin, but similar experiments using pVI-M1 show 
very little association with tubulin [209]. Although no literature to date has suggested pVI 
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Figure 8:  Contributions of NOD signaling during Ad5 infection. HeLa cells knocked 
down for NOD1 (A) or NOD2 (B) via siRNA were transduced with Ad5-WT or Ad5-M1. 
Results displayed as infectivity relative to siRNA control set to 100%. *p<0.05, 
**p<0.001 
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to specifically interact with microtubules or microtubule-associated proteins, these data 
imply a role for pVI in microtubule interactions. Recent studies show that the majority of 
incoming virions colocalize with dynein heavy chain in IFA experiments, as well as a 
high association with dynactin subunits [290]. They also show that adenovirus capsids 
only colocalize with DHC once they have egressed from clathrin-positive or EEA1-
positive locations, and immunoprecipitations using anti-hexon antibodies pull down 
dynein intermediate chain components 40 minutes post-infection. In vitro assessments 
imply that hexon directly associates with dynein, however this occurs in a pH-dependent 
manner, requiring a pH shift to at least 5.5. Since virus ruptures endosomes at very early 
times, this suggests that the hexon-dynein interaction is not physiologically relevant, at 
least from a pH-dependent context. These contradictions merit further study into how Ad 
exploits microtubule motor proteins, and what each motor’s individual contributions are 
during entry. 
DLC1 interactions with hexon are not physiologically relevant 
Previous reports indicate that light intermediate chain 1 (LIC1) is a critical 
component in recruiting Ad virions to dynein during infection [290]. Moreover, PKA-
phosphorylated LIC1 is necessary to efficiently translocate virus to the MTOC or 
perinuclear area 1 hpi [340]. However, the effect on viral infectivity was not assessed. 
Using siRNA knock downs, we asked how LIC1 specifically contributes to Ad infectivity 
during the entry process. We expected that if LIC1 is important for Ad accumulation near 
the nucleus, then knocking down LIC1 would restrict Ad infectivity. HeLa cells were 
transfected twice with siRNA against LIC1 or a control siRNA once every 24 hours. 
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Another 24 hours after the second transfection, cells were lifted and either saved for 
western blot or plated, rested, and transduced with a replication-defective Ad5 vector 
containing a CMV-driven luciferase transgene overnight. Approximately 15 hours after 
transduction, cells were lysed, and lysates assessed for luciferase activity. We found that 
LIC1 siRNA transfection reduced LIC1 levels in the cell by just over 40% (Figure 9). 
However, when assessing luciferase expression, we found little difference in infectivity 
between LIC1 and control knock down cells. This result suggests that although LIC1 
interacts with pH-primed hexon in vitro and non-phosphorylated LIC1 reduces virus 
accumulation at the nucleus an hour after entry, LIC1 is overall unimportant for Ad 
genome delivery. 
Dynein inhibition by Ciliobrevin D restricts WT Ad to endosomes during entry 
Although LIC1 appears unimportant for virus infectivity, a large body of literature 
still indicates that dynein function is critical during Ad entry. To elucidate the specific 
contributions of dynein on Ad endosomal escape, we utilized a recently developed 
specific small molecule inhibitor of the motor protein dynein, called Ciliobrevin D 
(CilioD). Ciliobrevins are a group recently designed small molecules that have nanomolar 
affinities for the dynein ATPase pocket of the DHC motor [341]. These are specific for 
dynein motors, as in vitro assays show they elicit no effect on kinesin-1 or -5 movement 
along microtubules. Others showed that inhibition mediated by these molecules is 
reversible in neuronal cell cultures [342, 343]. These results illustrate the usefulness of 
ciliobrevins in future studies to elucidate the contributions of dynein during infection at 
specific times without requiring constitutive dynein inhibition through siRNA 
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Figure 9: Effects of dynein LIC1 knockdown on Ad5 infectivity. DLC1 was knocked 
down in HeLa cells via siRNA, and cells were transduced with Ad5WT-luc virus. A. 
Western blot of whole cell lysates probed for DLC1 (DYNC1LI1). B. Luciferase 
expression in DLC1 and control knockdown cells transduced with increasing viral 
particles per cell (ppc). 
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knockdown or dominant negative overexpression models, minimizing the repercussions 
one sees when shutting down a critical transport pathway within the cell. 
We expected that inhibiting dynein with Ciliobrevin D (CilioD) would restrict 
Ad5-WT infectivity, in accordance with previous reports using dynein knock down or 
constitutive inhibition. Cells were pretreated with 50μM or 100μM concentrations of 
drug or 0.2% DMSO as a control for 30 minutes, and similarly infected as described 
above for Bx795 treatments. We found that transducing cells with Ad5-WTgfp in the 
presence of CilioD significantly restricts infectivity by more than 60% using 100μM 
concentrations of the drug (Figure 10A). We additionally anticipated that since pVI-M1 
does not colocalize with microtubules and Ad5-M1 cannot efficiently egress from 
endosomes, treatment with CilioD would have no effect of Ad5-M1 infectivity. To our 
surprise, we saw that CilioD enhances Ad5-M1gfp infectivity by 50% (Figure 10A). In 
fact, treating cells with 100μM CilioD equilibrated Ad5-WT and Ad5-M1 infectivities 
when cells were transduced with the same physical particles per cell. This was intriguing 
to us, suggesting that not only is Ad transport intimately linked to dynein for infectivity, 
but so is host-mediated restriction of Ad5-M1. Lysosomal and late endosomal 
movements throughout the cell’s cytoplasm is dependent on both dynein and kinesin 
associations [344-346]. Inhibiting dynein likely prevents lysosomes and/or autophagy 
machinery from translocating to Ad5-containing endosomes after lysis, thus giving Ad5-
M1 as much of an opportunity to infect a cell as the WT virus in the absence of dynein. 
 We wanted to further characterize the defect caused by dynein inhibition by 
assessing Ad5-WT kinetics in the cell during entry. We expected that infections with the 
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Ad5-WT in the presence of CilioD would recapitulate the phenotype we see with our 
Ad5-M1 virus: reduced accumulation at the perinuclear area and increased colocalization 
with gal3 endosomes. We utilized IFA to evaluate Ad5 transport within the cell, as well 
as its colocalization with gal3-positive endosomes, over the course of a 2 hour 
transduction. Cells were chilled on ice at 4°C in the presence of drug or vehicle control, 
30 minutes. Chilled virus + treatment was added to chilled cells, on hour, allowing virus 
to bind, but not endocytose. After binding, cells were washed three times with ice-cold 
PBS before being fed pre-warmed 37°C medium containing drug or vehicle. Cells were 
fixed and stained for gal3 and LC3, and virus localization was assessed. We saw that 
treatment with this drug leads to greater colocalization of Ad5-WT with gal3, implicating 
dynein’s significance in endosomal escape (Figure 10C). In addition to increased 
colocalization with ruptured endosomes, fewer virions accumulate at the perinuclear area 
over the course of two hours, further implicating dynein’s importance for proper Ad entry 
(Figure 10D). These data implicate some mechanism of dynein recruitment to endosomes 
that is dependent on the pVI-PPxY motif. 
Adenovirus infection requires BAG3 in a PPxY-independent manner 
Understanding what host proteins interact with the pVI-PPxY domain will lead us 
to further understand the mechanism by which incoming virions utilize microtubules to 
escape from endosomes. In vitro studies show that pVI interacts with a number of Nedd4-
family E3 ubiquitin ligases in a PPxY-independent manner [209]. These ubiquitin ligases 
contain a protein-protein interacting WW-domain sequence motif that recognize proline-
rich sequences, including PPxY motifs, in host proteins [347, 348]. Once engaged with a 
  
78 
 
Figure 10:  Changes in Ad5 localization upon dynein inhibition. A. HeLa cells treated 
with 50μM CilioD were transduced with Ad5-WT or Ad5-M1. Infectivity is displayed 
relative to DMSO vehicle treatments, set to 100%. B. Representative micrographs of cells 
transduced with 488-labeled Ad5-WT virus (green) in the presence or absence of CilioD. 
Cells were fixed and stained for galectin-3 (red). C. Percent of virus colocalized with 
galectin-3 over time. D. Percent of virus targeted to the perinuclear area (within 2μm of 
the nucleus) in the presence or absence of CilioD. *p<0.05, **p<0.001 
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protein, the ubiquitin ligase ubiquitinates both itself proteins in close proximity, generally 
targeting them to the proteasome for degradation [349]. Of these Nedd4 family ligases, 
Nedd4.2, but not Nedd4.1 or AIP4, depletion results in a modest restriction of Ad5 
infectivity that incompletely recapitulates the Ad5-M1 phenotype [209]. Thus, other 
WW-domain proteins capable of interacting with pVI via the PPxY sequence may be 
important to evade autophagy. 
BAG3 is a WW-containing protein part of a protein complex that facilitates the 
recognition of cargo targeted for autophagy [350, 351]. BAG3, along with E3-ubiquitin 
ligases, recruits ubiquitinated p62 and other adaptor proteins to bind cleaved LC3 and 
expand the autophagosome. Previous studies report that BAG3 knock down attenuates 
viral transgene expression when cells are infected with replication-defective Ad [352]. 
Since we observe that pVI remains within fragmented endosomes during Ad egress, we 
hypothesized that the pVI-PPxY motif recruits BAG3 complexes to ruptured endosomes, 
mediating Ad escape into the cytosol. To test this, we used siRNA to knock down BAG3 
in HeLa cells. After two transfections, cells were used for western blot or plated for 
transduction. BAG3 knock down or control-transfected cells were transduced with either 
Ad5-WTgfp or Ad5-M1gfp, and GFP expression was assessed 18-24 hours later. We 
expected that if pVI-PPxY facilitates BAG3 recruitment to ruptured endosomes to aid in 
virus escape, then Ad5-WT infectivity should be restricted to Ad5-M1 levels. However, 
we found that BAG3 knockdown restricts both Ad5-WT and Ad5-M1 infectivities to 
similar extents (Figure 11). This result suggests to us that, while BAG3 is critical for 
optimal Ad infection, the pVI-PPxY motif does not contribute to this effect. As 
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Figure 11: Ad5 infectivity in BAG3 knockdown cells. HeLa cells were transduced 
twice with BAG3 or control siRNA. 72 hours post initial transfection, cells were 
transduced with Ad5-WT or Ad5-M1. Results displayed as infectivity relative to control 
siRNA set to 100%. *p<0.05, **p<0.001 
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discussed, perhaps BAG3 knockdown reduces autophagy induction below the threshold 
required for optimal Ad infection. Alternatively, previous studies show that penton base 
overexpression in cells results in BAG3 accumulation at the nucleus, and this occurs in a 
PPxY-dependent manner. Although penton base is shed from the capsid early upon 
endocytosis, perhaps it mediates an important interaction with BAG3 to facilitate optimal 
infection. 
In vitro pVI-WT pull downs suggest multi-protein interactions 
Overexpression and pull down data indicate that, in addition to Nedd4-family 
ligases, pVI interacts with microtubules in a PPxY-dependent manner. Whether MT 
association is direct or indirect is still undetermined. To further probe potential host 
proteins interacting with pVI, we performed pull downs using His-tagged pVI-WT. HeLa 
cells were lysed and cell debris pelleted, and supernatants were biotinylated. After 
biotinylation, lysates were incubated with purified pVI-his protein or GFP-his as a 
control. Protein complexes were pulled down with his-tag-binding cobalt beads, washed 
with imidazole, subjected to western blot, and probed for biotinylated proteins. 
We found that, compared to background pull down protein interactions with GFP, 
a number of bands of various molecular weights are pulled down by pVI-WT (Figure 12). 
Some of these bands potentially correspond to dynein components, so we repeated the 
pull down with non-biotinylated lysates, and probed directly for dynein components. 
Unfortunately, the components we probed for either pulled down with both pVI and GFP 
incubations, or did not pull down at all (data not shown). We were unable to perform 
similar pull downs with pVI-M1, as we could not purify sufficient quantities of 
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Figure 12: Protein interactions with pVI via pull down. Cell lysates were biotinylated, 
quenched, and incubated with bacterially-derived recombinant HA-tagged pVI or GFP. 
Interacting proteins were pulled down via cobalt beads, washed, and eluted with 
imidazole. Eluates were run on western blot and probed with avidin-HRP. 
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his-tagged pVI-M1. Regardless, these data indicate that pVI specifically mediates a 
variety of interactions with host proteins. Further elucidation will likely reveal more 
information regarding these interactions. 
Influences of kinesin and capsid-associated protein IX during endosomal escape 
We next sought to elucidate the specific contributions of kinesin in Ad infection. 
A recent report implicates pIX-kinesin interactions for genome delivery [291]. The data 
suggest that pIX interacts with the nuclear pore complex (NPC) via kinesin, and kinesin-
mediated transport towards the cell periphery disrupts the NPC and fully disassembles the 
viral capsid, revealing the viral genome and facilitating its import into the nucleus. It is a 
widely-held belief that functional adenovirus docking at the nuclear pore complex (NPC) 
to deliver its genome has already penetrated into the cytosol, and thus is free of 
endosomal fragments [288, 289, 353, 354]. 
Using U2OS cells stably expressing mCherry-tagged gal3, we performed live-cell 
imaging to observe Ad virion trafficking in the cell during entry. We found that viral 
particles associate with gal3 in the periphery, and translocate to the nucleus while 
associated with the gal3-positive membranes. Interestingly, in contradiction to previous 
assumptions, we observed viral egress from ruptured endosomes occurring at the nucleus 
(Figure 13) [324]. Escape occurs in a fast, directed movement away from the nuclear 
periphery, indicative of microtubule transport. These data, combined with the reported 
data suggesting that pIX interacts with kinesin, led us to hypothesize that Ad egress from 
endosomes away from the nucleus is mediated by pIX associations with kinesin, such that 
newly cytosolic virus can traffic back to the nucleus and dock at the NPC. 
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Figure 13: Time-resolved imaging of Ad5 escape from endosomes. U2OS cells 
expressing mCherry-tagged galectin-3 were synchronously transduced with 488-labeled 
Ad5. Image collection started 30 minutes after transduction, and images were acquired at 
a rate of 5 frames per second. Particle tracking was performed with MTrackJ. 
  
85 
Protein IX-deleted Ad is defective for viral infection 
To test our hypothesis, we first generated and characterized a mutant Ad5 virus 
deleted for pIX (Ad5-ΔpIX). Previous reports show that Ad5-ΔpIX exhibits a 2-fold 
defect in infectivity when compared to WT virus, but where this defect occurs has not 
been entirely addressed [291]. Initially, it was suggested that pIX is important for genome 
delivery once the virus docks at the nuclear pore, however preliminary data in our lab 
may support additional roles of pIX, upstream of nuclear docking during the entry 
process. We generated our own GFP-expressing Ad virus that contains a 318-bp 5’ 
truncation of the pIX sequence (Ad5-ΔpIXgfp). This truncation produces an out-of-frame 
start codon that may potentially generate a 17-amino acid peptide, but this has not been 
assessed. We assessed the specific infectivity of purified virus, finding a 2-3-fold defect, 
consistent with previous findings (Figure 14A). Additionally, transfecting pIX on a 
plasmid into replication-competent virus producer cells restores the defect of Ad5-ΔpIX 
compared to empty vector transfections, suggesting the phenotype is specifically due to 
deleting (Figure 14B). 
We attempted to assess where the Ad5-ΔpIX defect occurs during entry. 
Indications that pIX interacts with kinesin suggested to us that pIX may act later in entry. 
To test this, we treated cells with either nocodazole or CilioD to respectively 
depolymerize microtubules or inhibit dynein and found that, when normalized to vehicle 
control treated transductions, both inhibitors restrict Ad5-ΔpIX virus by the same 
percentage when compared to Ad5-WT (Figure 15A & B). Furthermore, treating cells 
with Bx795 to inhibit autophagy-mediated restriction has no effect on Ad5-ΔpIX 
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Figure 14:  Characterization of Ad5-ΔpIX. A. HeLa cells were transduced with Ad5-
WT or Ad5-ΔpIX viruses in increasing physical viral particles per cell. Percent infectivity 
analyzed by flow cytometry. B. 293β5 cells were transfected with pcDNA 3.1 empty 
vector or containing full-length pIX, then transduced with Ad5-WT or Ad5-ΔpIX. 48 
hours post-transduction, supernatants were collected and added to HeLas, and GFP 
transgene expression assessed by flow cytometry. 
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Figure 15: Consequences of dynein and TBK1 inhibition on Ad5-ΔpIX infectivity. 
A-C. HeLa cells treated with 30μM nocodazole (A), 50μM CilioD (B), or Bx795 (C) 
were transduced with Ad5-WT or Ad5-ΔpIX. GFP transgene expression was assessed. 
Ad5-M1 used in CilioD as a control. *p<0.05, **p<0.001 
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Figure 16: Influences of pIX-deficient virions on Ad5 entry. A. Representative 
micrographs of cells transduced with 488-labeled Ad5-WT or Ad5-ΔpIX virus (green). 
Cells were fixed and stained for galectin-3 (red). B. Quantification of galectin-3 puncta 
present within cells over time. C. Percent of virus colocalized with galectin-3. *p<0.05, 
**p<0.001 
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infectivity, similar to results observed in Ad5-WT transduction (Figure 15C). Taken 
together, these data indicate that the defect generated by pIX-deleted virions occurs after 
virion uptake by the cell and its evasion of autophagy. 
Capsid-associated pIX aids virus in endosomal escape 
We next asked whether Ad5-ΔpIX escapes from endosomes as efficiently as Ad5-
WT. We performed synchronous infections with fluorescently labeled virus, and assessed 
colocalization of virions with gal3 over time. We found that, although both Ad5-WT and 
Ad5-ΔpIX viruses induce the same number of gal3 puncta at a given time point (Figure 
16B), an increased percentage of Ad5-ΔpIX virus colocalizes with gal3-positive 
membranes at 1 and 2 hpi compared to Ad5-WT-transduced cells (Figure 16C). In our 
dynein inhibition assays we see similar increases in virion colocalization with gal3, so we 
next asked whether the mutant virus also correspondingly fails to accumulate at the 
perinuclear area. Interestingly, the number of Ad5-ΔpIX virions present within 2μm of 
the nucleus are comparable to Ad5-WT infections at 30 minute and one hour time points, 
although we do see a small but significant decrease in Ad5-ΔpIX accumulation at 2 hours 
post-infection (Figure 17A). However, of those perinuclear virions, again more virus is 
associated with gal3 in Ad5-ΔpIX infections compared to WT (Figure 17B), suggesting 
that virus-containing endosomes traffic towards the nucleus, but the virus cannot escape 
in a timely manner. Taken together, these data suggest that Ad5-ΔpIX virus ruptures 
endosomes as efficiently as the WT virus, but cannot competently egress from them. 
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Figure 17: Perinuclear accumulation of Ad5-ΔpIX. A. Percent of Ad5-WT and Ad5-
ΔpIX virus targeted to the perinuclear area (within 2μm of the nucleus). B. Percent of 
perinuclear virus colocalized with galectin-3. *p<0.05 
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Cell lines stably expressing pIX enhance Ad infection 
To further elucidate the contributions of pIX during Ad egress from endosomes, 
we asked what domain of pIX is critical for the WT activity of the protein during virion 
entry. pIX consists of three putative domains: an N-terminal domain (AAs 1-57) that is 
important for triskelion formation and integration into the virion capsid, a C-terminal 
domain (AAs 90-140) that is exposed to the environment upon capsid destabilization, and 
an alanine-rich linker domain connecting the two. To our knowledge, the function of 
these three domains in virus-host interactions during the entry steps has not been 
assessed. Others have postulated that since the C-terminus of pIX becomes exposed upon 
capsid destabilization, this domain could facilitate interactions with host proteins to aid in 
entry. We established HeLa cell lines stably overexpressing HA-tagged constructs of 
either the full-length form of pIX (HA-pIX), or a C-terminal truncated form lacking 
amino acids 91-140 (HA-pIXΔCTD). We hypothesized that if the C-terminal domain is 
important for virus-host interactions, then the HA-pIX construct will constitutively 
interact with its binding partner(s), essentially competing for Ad5-WT interactions during 
virus entry. Conversely, if the pIX CTD is important for such interactions, then HA-
pIXΔCTD-expressing cells should not actively compete for virus binding, thus HA-pIX 
cells will restrict Ad5-WT infection while HA- pIXΔCTD will not. We also expected that 
neither cell line would restrict Ad5-ΔpIX virus. However, we found that compared to the 
virus transductions in WT HeLa cultures, both virus’ infectivities are enhanced almost 
50% upon transduction into cells overexpressing HA-pIX (Figure 18). HA-pIXΔCTD 
stable cells also slightly enhance viral infectivity in a pIX-independent manner, but not as 
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drastically as HA-pIX cells (Figure 18). This result suggests that soluble pIX in cells 
augments viral infectivity, however the mechanism by which this occurs was not tested. 
Inhibiting KLC1 restricts Ad infection in a pIX-independent manner 
Finally, we sought to address the contributions of kinesin motors in Ad entry. To 
assess Ad infectivity in the absence of kinesin, we used siRNA to knock down kinesin 
light chain 1 (KLC1), the component of the kinesin complex responsible for binding 
cargo [355]. siRNA transfection yielded greater than 70% knockdown of KLC1, and 
transducing Ad5-WT in knockdown cells significantly decreases kinesin expression, 
resulting in over 50% restriction in infectivity compared to control siRNA cells, similar 
to previously published results [291] (Figures 19A-C). As stated above, previous reports 
propose that kinesin interactions with pIX are important for viral genome delivery. 
However, whether knocking down KLC1 has an effect on Ad5-ΔpIX infectivity was not 
assessed. We found that KLC1 knockdown restricts Ad5-ΔpIX infectivity just as much as 
Ad5-WT infectivity when compared to control siRNA cells (Figure 19C). This was 
striking to us, as it contradicted the implications from previous reports. Instead, these data 
suggest that pIX is not critical for the contributions of kinesin in Ad infection. 
KLC1 knockdown by siRNA may contribute to undesirable effects on cell 
processes, which could potentially affect general Ad infection, and mask its contributions 
to Ad entry. To confirm whether the defect in Ad5-ΔpIX infectivity is due to an inability 
to interact with kinesin during entry, we generated stable HeLa cell lines overexpressing 
the pIX-interacting component of KLC1, the tetratricopeptide repeat (TPR) domain. TPR 
domains are protein-protein interaction domains containing up to six tandem repeats that 
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Figure 18: Consequences of pIX overexpression on Ad5 infectivity. HeLa cells stably 
expressing HA-tagged full-length pIX or pIXΔCTD were transduced with Ad5-WT or 
Ad5-ΔpIX virus. GFP transgene expression was assessed by flow cytometry. Relative 
infectivity standardized to WT cells. *p<0.001
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Figure 19:  Effects of KLC1 knockdown on Ad5 entry. A. HeLa cells were transfected 
twice with KLC1 or control siRNA. Lysates were probed for KLC1 and actin to assess 
knock down efficiency. B. Cells transfected with control or KLC1 siRNA were fixed and 
stained for lysosomes with anti-LAMP-1 antibody (red).  Control siRNA cells show 
lysosomal dispersion throughout the cytoplasm (left panel), while cells knocked down for 
KLC1 accumulate lysosomes at the perinuclear area (right panel). C. KLC1 and control 
siRNA-treated cells were transduced with Ad5-WT or Ad5-ΔpIX virus. Infectivity 
assessed by GFP expression is normalized to control siRNA transductions. D. HeLa cells 
stably expressing cherry-tagged KLC1-TPR (Cherry-TPR) were transduced with Ad5-
WT or Ad5-ΔpIX virus, and GFP transgene expression measured by flow cytometry. 
Infectivity is normalized relative to untransduced HeLa cells. E. Colocalization of virus 
with galectin-3 in KLC1 knockdown cells compared to control siRNA during time 
course. *p<0.05, **p<0.001 
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are 34 amino acids long [111]. TPRs are responsible for recruiting cargo to the kinesin 
complex, and ATPase activity within the kinesin heavy chain (KHC) allows the cargo to 
traffic along microtubules to a specific destination [356, 357]. Our stable HeLa cell lines 
overexpressing just the TPR domain of KLC1 should act as a dominant-negative form of 
kinesin: while the TPR can interact with and bind cargo, it cannot form a complex with 
the KHC, and as such is unable to traffic within the cells by microtubules. We 
hypothesized that if pIX-TPR interactions are important for infection, then soluble TPR 
would interact with WT virus, preventing the virus from properly associating with the full 
kinesin complex, and restrict virus infectivity. Further, if the defect in Ad5-ΔpIX 
infectivity is due to an inability to bind kinesin, then there should be no effect on the 
infectivity of the Ad5-ΔpIX virus. However, our data confirm the results produced by 
siRNA knockdown of KLC1, yielding similar restrictions in both virus’ infectivity 
(Figure 19D). Taken together, these data suggest that although the defect in Ad5-ΔpIX 
occurs prior to endosomal escape, it is not due to an inability of the virus to interact with 
kinesin. 
KLC1 knock down enhances early Ad escape from endosomes 
Although KLC1 knock down restricts Ad infectivity in a pIX-independent 
manner, we were still interested in further characterizing the contributions of kinesin in 
Ad entry. We reasoned that since our live cell imaging assays show viral egress from 
endosomes towards the cell periphery, kinesin knock down may limit Ad egress from 
ruptured endosomes. To test if KLC1 knockdown affects endosomal escape, we used IFA 
to assess Ad5-WT virus colocalization with gal3 in KLC1 or control siRNA-transfected 
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cells. We found no difference in the ability of virus to rupture endosomes as assessed by 
the number of gal3 puncta, nor in the percent of virions colocalized at the nucleus. 
However, although we found similar percentages of virions contained within ruptured 
endosomes at later times post-entry, we reproducibly saw that virions in KLC knocked 
down cells colocalize with fewer gal3 puncta at the 30 minute time point compared to 
control cells (Figure 19E). Since the number of ruptured endosomes is consistent, these 
results suggest that, opposite to our hypothesis, kinesin actually confines Ad to ruptured 
endosomes early in the entry process. Furthermore, as knocking down kinesin elicits no 
difference in WT virus to egress from ruptured endosomes at later times post-entry, this 
suggests that kinesin’s contribution to infection may be early in the entry process.
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CHAPTER IV 
 
DISCUSSION 
 
 Viruses have co-evolved alongside their hosts for millions of years in a sort of 
arms race, with the host continually developing mechanisms to restrict viral infection, 
and vice versa the virus improving its methods to elude detection and subsequent 
restriction. Viruses have the capacity to specifically manipulate cell activities to their 
advantage, making them great tools in probing very complex pathways and protein 
functions within the host. Elucidating both the mechanisms of host restriction of viruses, 
as well as methods of pathogen evasion of such restrictions, are important to design 
treatments for preventing disease. Our lab uses adenovirus (Ad) to probe some of the host 
responses to pathogen infection and assess the approaches utilized by Ad to elude 
restriction. Understanding the contributions of distinct mechanisms of evasion that allow 
for optimal Ad genome delivery are also useful in the context of replication-defective Ad 
vectors, which are currently being pursued as potential vaccine candidates to deliver 
transgenes to the nucleus. As such, this study focuses on host responses to Ad as a barrier 
to viral entry and genome delivery. We specifically concentrate on mechanisms of viral 
evasion of restriction by autophagy after endosomal rupture and the methods of viral 
egress into the cytoplasm. 
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Consequences of Ad-induced membrane rupture 
Significance of galectin recruitment  
Our lab and others showed that galectins 3, 8, and 9 accumulate at endosomes 
ruptured by entering pathogens [72]. Knocking down galectin-8 in cells enhances 
Salmonella replication, however gal3 and gal9 knock down experiments showed no effect 
on replication. Similarly, we previously showed that siRNA against gal8 restores Ad5-
M1 infectivity, suggesting that gal8 is important for host restriction of Ad5 in a pVI-
PPxY-dependent manner. Gal8 recruits NDP52 to sites of damage faster than the 
ubiquitin-binding process in Salmonella infections (1 hour compared to 4 hours, 
respectively). This is especially important in Ad infection, as most virus would already 
have the opportunity to deliver its viral DNA to the nucleus by 4 hours. This result 
implies that gal8 may have a specific role during pathogen-induced autophagy rather than 
the autophagic process required for general host cell maintenance. 
It is interesting that gal8 knockdown enhances pathogenicity but there is no 
obvious change when similar knock downs are performed for gal3 and gal9. Both gal8 
and gal9 contain tandem-carbohydrate recognition domains connected by a linker 
sequence. Gal8’s C-terminal carbohydrate recognizing domain (C-CRD) is has a higher 
affinity for N-linked glycans than its N-terminal CRD (N-CRD), suggesting that the C-
CRD binds cell surface glycans revealed after endosomal rupture [358]. Gal8 and gal9 C-
CRDs have 60% similarity, implicating that they both have the capacity to bind these 
sugars. However, although gal8 and gal9’s N-CRDs share ~53% similarity, they each 
interact with different saccharide molecules [358-360]. Additionally, while gal8 is widely 
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distributed across most tissues, gal9 is primarily found in the kidney, thymus, and 
synovial fluid. These differences may account for both galectins having the capacity to 
bind ruptured endosomes, but only gal8 enacting a restrictive effect on incoming 
pathogens. 
Galectin-3 is structurally unique in that it contains one CRD at its C-terminus, 
connected to a disordered N-terminal tail containing 8 tandem repeats of the sequence Y-
P-G-X(3)-P-G-A. In high concentrations, gal3 oligomerizes into pentameric structures 
through this tail domain, and although N-terminally-truncated mutants still bind sugar 
moieties, the tail is essential for extracellular gal3 signal transduction and cell adhesion 
functions [361-365]. We initially hypothesized that endosome-associated gal3 
oligomerizes via its tail to cage Ad virions from efficiently egressing. Precedence for this 
proposal arose from noticing that the gal3 tail sequence contains a LXGG sequence motif 
downstream of the N-terminal tail, at the beginning of the CRD. Ad protease (AVP) 
recognizes and cleaves LXGG sequences, which led us to ask whether virion-associated 
AVP has the capacity to cleave gal3 during entry. Additionally, previous reports show 
that during Leishmania donovani (L. donovani) infection, extracellular gal3 binds 
bacterial glycans to act as a DAMP upon encountering macrophages. However L. major 
cleaves the tail domain of gal3, restricting its function [366]. These data led us to assess 
whether Ad protease cleaves gal3 and test if a 113-amino acid N-terminally truncated 
gal3 acts as a dominant negative protein to enhance Ad infection. However, we found 
that Ad transduction does not cleave gal3 within one hour after entry, and stably 
expressing a cherry-tagged N-terminal truncation of gal3 in MEFs (which do not 
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endogenously express gal3) or HeLa cells has no effect on Ad5-WT or Ad5-M1 
infectivities compared to full-length gal3 (Figure 20). 
These results, in addition to the results reported in Salmonella replication upon 
gal3 knockdown, indicate that although gal3 and gal9 are recruited to sites of rupture, 
they have no function with regard to intracellular infection in vitro. All three of these 
galectins function in extracellular signaling pathways, and must be secreted from the 
cytoplasm (reviewed in [367]). Perhaps they are simply present in the cytoplasm prior to 
secretion, and encountering glycans in the cytosol keeps them within the cell. 
Intriguingly, galectins do not contain classic secretion signal peptides [368]. It is possible 
that galectin secretion relies on exocytosis mediated by the autolysosomal pathway, and 
galectin-bound endosomal fragments act as a danger signal to neighboring cells. 
However, as neither of these proposals have been examined this remains pure conjecture. 
TBK1 contributions to autophagosome formation 
Ads must escape from endosomes to properly traffic to the nucleus. To do so, the 
virus fragments the endosome by utilizing the membrane lytic activity of its capsid 
protein VI (pVI). We show here and in other reports that membrane rupture alerts the cell 
to infection, activating a number of defenses. This response mediates both innate and 
adaptive responses in a cell, allowing a healthy host to limit infection. By using a direct 
marker of adenovirus-mediated vesicle rupture, we can elucidate the innate responses in a 
temporal manner, and further understand how the virus attempts to inhibit the virus 
intrinsically before it can establish an infection. 
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Figure 20: Ad5 infectivity in cells expressing N-terminal tail-deleted galectin-3. A. 
HeLa cell lysates transduced with Ad5-WT were probed for galectin-3 to assess cleavage. 
B-C. Hela cells (B) or MEFs (C) stably expressing mCherry-tagged full-length (Gal3-FL) 
or a 113-amino acid N-terminally-deleted galectin-3 (Gal3-Δ113) were transduced with 
Ad5-WT or Ad5-M1.  GFP-positive cells were assessed by flow cytometry. 
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Autophagosome formation around damaged endosomes is a near-immediate 
response to vesicle rupture, and one of the first attempts for the cell to restrict viral 
penetration into the cytosol. Mutant Ad virions unable to efficiently egress from ruptured 
endosomes before sequestration by autophagy are delivered to lysosomes for degradation. 
Our lab and others suggest the host’s quick response to pathogen-mediated vesical 
damage is facilitated by gal8-dependent recruitment of restrictive molecules [72]. In 
Salmonella infections, gal8 recruitment of NDP52 is necessary to mediate restriction. 
However, we previously found that knocking down NDP52 restricts Ad5-WT infectivity 
but has no effect on Ad5-M1 [324]. This result suggests that, in contrast to the data 
reported in the Salmonella model, gal8 recruitment of NDP52 is important for optimal Ad 
infection rather than viral restriction. Perhaps Ad infection differentially triggers gal8 
interactions with NDP52 compared to Salmonella-mediated pathogenesis. How this 
occurs and its relevance in signaling pathogen evasion may reveal subtle but distinct 
mechanisms utilized by the host to specifically target unique pathogens for restriction. 
Our data also suggest that the adaptor protein kinase TBK1 is essential for 
autophagy machinery to sequester the endosome-associated Ad virions. These data 
strongly implicate a role for one of the adaptor molecules, p62 or optineurin (OPTN), in 
resolving Ad restriction by the host. Similar to NDP52, preliminary data do not implicate 
p62 in Ad restriction (data not shown), leaving OPTN. Whether OPTN is recruited to 
membrane damaged by Ad has not been assessed. IFA experiments to test OPTN 
recruitment to ruptured endosomes and transduction assays in OPTN knock down cells 
will begin to elucidate the contributions of this adaptor, if any. Further investigations 
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assessing whether Ad entry induces OPTN phosphorylation in a TBK1-dependent 
manner may further resolve the mechanisms of autophagosome formation during Ad 
infection. 
We also show here that that treating HeLas with Bx795 prevents Ad-dependent 
LC3 cleavage after 1 hour synchronous infection. This differs from previous reports that 
LC3 cleavage occurs in tbk1-/- MEFs or MEFs treated with Bx795, but they do not 
mature and fuse with lysosomes [83]. This result may be due to cell type differences 
(cultured vs. primary cells), or a difference in the way autophagy is induced in either 
system. In our system, autophagosome formation is induced by vesicle damage, whereas 
in the MEF assays, cells were starved for 4 hours to facilitate autophagy. Starvation-
mediated autophagy occurs via mTOR inactivation, which our data suggest does not 
regulate Ad-mediated autophagy. Although p62 phosphorylation by TBK1 is critical for 
autophagosomal maturation in the MEF assays, these observations may suggest that 
TBK1 functions differently depending on the mechanism of signaling. Further studies are 
required to elucidate TBK1 activities upon signaling through different pathways. 
Previous reports implicate that host sensing of Ad through the cGAS/STING 
complex stimulates TBK1 to promote IRF3 activity [369-371]. Inhibiting signaling via 
this complex in both cell lines and primary cells reduces mRNA transcription of 
molecules important for type I IFN responses, including IFNB, STAT1, and ISG15. Our 
data, in conjunction with these studies, suggest that TBK1 is important to properly 
mediate antiviral activity against Ad, both as a signaling component for mounting a 
suitable innate immune response and as a restriction element during autophagosome 
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formation. Our observations contribute to the growing body of literature that implicates 
TBK1 as a critical node or junction kinase, similar to mTOR and PKA, which function in 
sensing distinct viral DAMPS and accurately directing signals through explicit host 
signaling pathways to mediate specific antiviral responses (reviewed in [372]). 
One further caveat to our TBK1 studies is that inhibition via Bx795 treatment is 
also reported to inhibit five other host kinases: IKKε, PDK1, Aurora B, ERK8, and 
MARK3 [327]. Although Bx795 inhibits these kinases >5-fold less potently than TBK1 
at micromolar concentrations, it is worth considering whether affecting their activities 
may skew our results. PDK1 and Aurora B inhibition would stimulate autophagy through 
mTOR inactivation; since mTOR function is dispensable for Ad-mediated autophagy 
induction, these are likely not involved in restricting Ad. Furthermore, we do not see a 
difference in the number of LC3 puncta induced in cells treated with Bx795 or vehicle 
control, indicating that these kinases are not affected. MARK3 is a microtubule-
associated kinase, and is not implicated in autophagy. IKKε interacts with TBK1 to 
activate NF-κB [373], but no literature reports an involvement in autophagosome 
maturation. However, observations do implicate autophagy stimulation through ERK8 
[374]. ERK8, or MAPK15, localize to starvation-induced autophagic structures via LC3 
interactions, and its activation is mediated by hydrogen peroxide-induced ROS 
production. Thus, Bx795 treatment may implicate a role for ERK8 in Ad infection in 
addition to, or instead of, TBK1. To further address this, Ad transduction studies can be 
performed using either other chemical inhibitors of TBK1 or by stably overexpressing a 
kinase-dead mutant form of the protein. Chemical inhibitors may be preferential since 
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they are typically reversible, minimizing potential long-lasting effects from dominant 
negative expression assays. One inhibitor, MRT67307, might be useful in this application 
[375]. Nanomolar concentrations of this drug inhibit nearly 90% of TBK1 activity, but 
less than 20% of ERK8 activity. Additionally, with the exception of MARK3, it does not 
inhibit the other kinases affected by Bx795. This inhibitor would be useful to specifically 
demarcate the contributions of TBK1 to autophagy induction. 
ROS influences Ad-induced autophagy signaling 
 The autophagy-inducing signaling molecules activated to restrict Ad during entry 
in a pVI-PPxY-dependent manner still remain unknown. Many bacteria that rupture 
endosomes activate autophagy via an mTOR-dependent pathway, mimicking amino acid 
starvation in the infected cell [58-60]. Data from our collaborator suggest that mTOR 
signaling does not affect Ad-mediated restriction by autophagy, implying that membrane 
damage is somehow differentially recognized in cells depending on the mechanism of 
rupture. We corroborated this evidence using inhibitors of the AMPK pathway, which is 
an upstream signaling molecule of mTOR. Although gal8 knockdown enhances 
Salmonella and Ad infections, autophagy is still activated in these cells but not found 
colocalized with pathogens, indicating that gal8 is involved in properly targeting 
autophagic machinery rather than inducing it. Clarifying whether there are differences in 
host cells recognizing damaged membranes will further aid our understanding how 
different pathogens mediate and exploit host responses and processes. 
We have seen previously that high concentrations of ROS are quickly produced 
upon membrane rupture by Ad, leading to the logical proposal that ROS is involved in 
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such signaling. However, we find here that multiple ROS-mediated signaling pathways 
have no differential effects on Ad5-WT or Ad5-M1 infectivities. Inhibiting either 
ERK1/2 or p38 has no effect on Ad infectivity, similar to the results found upon 
inhibiting mTOR signaling pathways. Additionally, preliminary data suggest that treating 
cells with the ROS scavenger N-acetyl-cysteine restricts both viruses similarly (data not 
shown). These data implicate a pVI-PPxY-independent importance of ROS during 
infection and further suggest that ROS does not facilitate autophagy-mediated restriction 
of Ad5-M1, and likely do not merit continued investigation in regards to PPxY-
dependent autophagy evasion. Further studies are required to pinpoint the signaling 
pathway(s) induced by Ad membrane damage to initiate autophagosome formation. 
Beclin-1 and the PI3K signaling pathway in Ad-induced autophagy 
We previously showed that knocking down beclin-1 by siRNA restores Ad5-M1 
infectivity 2-fold, indicating a role for beclin-1 in signaling to activate autophagosome 
formation. Beclin-1 is a major component of mTOR-dependent and -independent 
autophagosome initiation. Beclin-1-mediated autophagy requires a core complex 
consisting of Beclin-1, a protein kinase Vps15, and the class III phosphoinositide 3-
kinase (PI3K) Vps34. In mammalian cells, this core complex interacts with over 10 
different regulatory proteins to mediate autophagosome formation and/or vesicle 
trafficking (reviewed in [376]). Unsurprisingly, another pathway seemingly involved in 
autophagy-mediated restriction of Ad is PI3K signaling. We previously showed that 
treating cells with the class I/III PI3K inhibitor 3-MA also partially restores Ad5-M1 
infectivity approximately 2-fold. Interestingly, treating beclin-1 knockdown cells with 3-
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MA synergistically enhances Ad5-M1 infectivity 8-fold, but only improves Ad5-WT 
activity by 30%. These data suggest that PI3K and Beclin-1 act epistatically to restrict Ad 
entry, and the pVI-PPxY motif is critical to evade this restriction. However, another 
publication proposed that 3-MA has a dual role in autophagic flux depending on the cell 
conditions [377]. Their results show that while treating cells with 3-MA does restrict 
autophagy induction under starvation conditions, it surprisingly enacts the opposite 
function when cells are under normal “full” conditions, that is cells fed DMEM 
supplemented with 10% FBS. We have previously shown that exhausting autophagy 
machinery via transfecting cells with an empty plasmid vector fully restores Ad5-M1 
infectivity. Thus, under our conditions, treating cells with 3-MA prior to Ad5-M1 
transduction may partially exhaust autophagy machinery, enhancing infectivity. The 
synergistically enhanced phenotype observed in beclin-1 knockdown cells may be due to 
further inhibiting the capacity of autophagosome nucleation. 
Designing experiments to reveal autophagy induction by Ad can be difficult, as 
many previously established experimental systems that limit autophagy do so by 
temporally changing autophagic flux instead of shutting down its actual stimulation. For 
adenovirus, these results can skew our interpretation of the data. As such, experiments 
need to be carefully designed to specifically assess mechanisms of autophagy induction 
rather than changes in autophagic flux. 3-MA enhancement of autophagy under nutrient-
rich conditions starts between 3 and 6 hours of treatment, which could suggest that 3-
MA’s effects on autophagy would not affect Ad5-M1 infectivity, but more studies need 
to be performed to fully tease out this pathway. Wu, et al. further show that while 3-
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MA’s effect on class I PI3K activity is long-lasting, its inhibitory effects on class III 
activity is transient. The class III PI3K complex interacts with beclin-1, adding more 
complexity in interpreting these results. In contrast, their data suggest that another PI3K 
inhibitor, wortmannin, transiently affects class I PI3K, but persistently inhibits class III 
PI3K, even after 9 hours. It would be interesting to determine if the same enhancement in 
Ad5-M1 infectivity is seen in beclin-1 knockdown cells treated with wortmannin 
compared to 3-MA. This experiment would strengthen the results observed with 3-MA, 
further implicating PI3K involvement in Ad5-M1 restriction. 
If we maintain that both PI3K signaling and beclin-1 are critical in nucleating 
autophagosome formation, it is logical to assess what proteins are in complex with these 
molecules during Ad entry. Bcl-2 is a negative regulator of beclin-1, which perpetually 
binds beclin-1 unless physically displaced by competing protein-protein interactions or 
post-translational modifications (PTMs) on either protein. Bcl-2 must be displaced to 
activate beclin-1 and induce autophagy. Our data here suggest that chemically blocking 
Bcl-2 phosphorylation by JNK or ERK in the host has no effect on Ad infectivity, 
suggesting that Bcl-2-specific PTMs do not mediate autophagosome formation during Ad 
entry. However, these data do not eliminate the possibilities that Bcl-2 is supplanted by 
another protein or if beclin-1 is altered by PTMs. Testing whether Bcl-2 displacement or 
PTMs are important for beclin-1-mediated Ad restriction would further help to determine 
the specific mechanisms of Ad-induced autophagy. Previous students in our lab tested the 
effects of Bcl-2 overexpression on Ad in THP-1 cells. We expected that if Bcl-2 
competitively interacts with beclin-1, then overexpressing Bcl-2 will restore Ad5-M1 
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infectivity but have no effect on Ad5-WT. However, their experiments found no effect on 
Ad5-M1 infectivity (data not shown). This result suggests that increasing Bcl-2 
concentration in the cell, and thus its capacity to bind beclin-1, is not important for 
mediating Ad infection. Alternatively, these data may suggest that beclin-1 is post-
translationally modified to remove Bcl-2 during Ad entry, potentially explaining why 
increasing Bcl-2 in the cell has no effect on Ad infectivity. 
Additional tests can be performed to assess if beclin-1 is altered by PTMs during 
Ad transduction, such as assessing its ubiquitination or phosphorylation status. If PTM 
modification does occur, we can further focus on assessing the proteins involved in Ad-
induced autophagosome formation. Reports indicate that beclin-1 is ubiquitinated by 
TRAF6 on Lysine-117 or phosphorylated by DAPK on Threonine-119 [378, 379]. To 
date, neither TRAF6 nor DAPK are implicated in Ad entry. If beclin-1 is modified by 
these proteins, then we can test whether ubiquitination or phosphorylation is a critical 
factor. An easy assessment of Beclin-1 PTM is to probe for beclin-1 on western blot 
during early Ad transduction. If Beclin-1 is ubiquitinated, then a clear shift in molecular 
weight from ~50kDa to 58kDa or higher should be observed. Alternatively, 
phosphorylation can be assessed using Phos-Tag SDS-PAGE, where phosphorylated 
proteins run through the gel much slower than non-phosphorylated proteins. Therefore, 
comparing infected lysates to uninfected lysates would inform us which PTM occurs 
upon Ad entry. Testing whether either TRAF6 or DAPK is specifically important in Ad 
entry could be performed via chemical inhibition or siRNA knock down of either protein. 
TRAF6 activity is important in NF-κB responses during Ad infection, and is activated 
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through TLR4 signaling, but this occurs late in infection [380]. DAPK has no known 
effect on Ad infection. It is regulated by calmodulin and increases caspase-mediated cell 
death in HHUA epithelial cells [381]. Thus, knocking down DAPK may not be a viable 
experimental system and may require a more intricate assessment. Rather than knocking 
down these proteins, we could instead generate cell lines expressing beclin-1 alanine 
point mutants which cannot be either ubiquitinated or phosphorylated. We would expect 
that if either PTM is important for Ad5-M1 restriction, then cells containing point 
mutants would show enhanced Ad5-M1 infectivity. 
If the Bcl-2-beclin-1 complex is dissociated through protein competition, then we 
can assess the contributions of other proteins that regulate beclin-1-mediated autophagy 
induction. Many molecules are implicated in such regulation, including UVRAG and 
Atg14L [382-384]. These regulators are both implicated in activating autophagy through 
beclin-1, however they bind beclin-1 mutually exclusively of each other [385]. UVRAG 
knock down in cells does not affect autophagic flux, but mainly localizes to Rab9-
positive late endosomes. Atg14L is found in the ER and associates with membranes 
containing positive curvature [386]. It is implicated in both autophagosomal initiation and 
LC3 conjugation to phagophore membranes [383, 384]. It recruits class III PI3K to the 
ER and partially colocalizes with the autophagy initiation molecule Atg16L. This may 
implicate a role for Atg14L-mediated autophagy during Ad entry. Atg14L-induced 
autophagy is hijacked by the intracellular pathogen Anaplasma phagosytophilum, 
presumably to deliver nutrients to the bacterium [387]. However, whether Atg14L is 
important in viral infections is not well characterized. Testing whether UVRAG or 
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Atg14L is important for Ad5-M1 restriction can further delineate Ad-mediated induction 
of autophagy. 
Taken together, these data suggest that Ad-mediated membrane rupture during 
entry induces autophagosome formation through mTOR-, ROS-, and starvation-
independent mechanisms. Beclin-1 and the class III PI3K complex appear to be 
intimately involved in restricting Ad5-M1, suggesting that endosome rupture stimulates 
anti-viral innate responses through this complex. Performing the assays proposed above 
will help delineate the specific contributions of beclin-1-associated host molecules in 
inducing autophagosome formation to restrict Ad entry. Other studies to determine 
additional host proteins recruited to sites of membrane damage by Ad may also direct 
future investigations in elucidating mechanisms of Ad escape. Overall, this will not only 
help our understanding of Ad evasion of autophagy, but also may contribute to our 
comprehension of the complexity of autophagy signaling pathways and how various 
stimuli differentially induce autophagosome formation. 
Protein VI PPxY motif – recruiting host proteins 
Data from our lab clearly indicate that the pVI-PPxY motif is required for viral 
evasion of autophagy and penetration into the cytoplasm. These results suggest that 
endosomal escape is important for Ad evasion of host restriction responses, but that does 
not seem to be the whole story. We see that Ad deleted for pIX (Ad5-ΔpIX) is also 
retained in endosomes, but is not restricted by autophagosomes (Figures 15 & 16). Live 
cell imaging experiments suggest that WT virions traffic through the cell while remaining 
within gal3-positive membranes, only egressing once they traffic to the nuclear 
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periphery. These observations suggests that evading autophagy depends on more than just 
endosomal escape, implicating a multi-step process during viral egress: virus damages 
endosomes, moves away from sites of targeted autophagy machinery to evade restriction, 
then egresses from endosomes at a later time once the virus is no longer under threat of 
sequestration. Perhaps the PPxY motif mediates viral trafficking away from sites of 
autophagosome formation, and some other protein – possibly pIX – is required to 
facilitate the subsequent act of penetrating into the cytosol. This hypothesis requires more 
testing to elucidate the dynamics of Ad entry over time. Specifically, understanding what 
the PPxY motif recruits and/or interacts with will reveal its importance in evading 
sequestration by autophagosomes. 
Other reports indicate that the pVI-PPxY motif is important to interact with 
Nedd4-family ubiquitin ligases in the cytoplasm, and is necessary to restrict the PML-
associated host restriction factor Daxx [209, 325]. Nedd4.2 ubiquitinates pVI-WT but not 
pVI-M1, and siRNA against Nedd4.2 partially inhibits Ad5-WT infectivity, but not to 
Ad5-M1 levels. Similarly, Daxx-depleted cells partially restores Ad5-M1 infectivity, but 
not completely to WT levels. These reports suggest a 2-pronged requirement for pVI-
PPxY during infection: first during entry, Nedd4.2-dependent ubiquitination affects the 
protein’s function; and second, once the viral genome is delivered to the nucleus, pVI 
inhibits Daxx from interfering with early stages of replication, and further appears 
important for initial viral transcription. Although the second prong is important, it is 
necessary to design experiments that separate these effects to specifically assess the 
contributions of pVI-PPxY during entry. 
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The contributions of pVI ubiquitination 
The PPxY-dependent interaction with Nedd4.2 enables Ad accumulation at the 
nucleus, implicating that this process is important for pVI function during entry. 
However, the contributions of pVI ubiquitination by Nedd4.2 are still unresolved. 
Moreover, whether recruited Nedd4.2 ubiquitinates other viral or host proteins, and the 
influences of these modifications are also unknown. However, it is practical to initially 
focus on whether pVI ubiquitination contributes to viral entry. Transiently transfected 
pVI-WT highly associates with microtubules, but pVI-M1 does not. 
Whether microtubule interactions are dependent on the ubiquitin status of pVI is 
unknown, although the observation that Nedd4.2 knockdown reduces Ad accumulation at 
the nucleus would suggest that this is the case. Intriguingly, the Wodrich lab has mapped 
pVI ubiquitination to a single lysine. They found that mutating this residue to arginine or 
alanine has no effect on viral infectivity, suggesting that specific ubiquitination of pVI is 
dispensable for Ad entry. This result further implies that pVI recruitment of Nedd4.2 is 
important to mediate the ubiquitination of other proteins, or enacts some other function at 
the site of vesicle rupture. Whether these proteins are viral, host, or both is not yet 
identified. Penton base also contains PPxY motifs, and is ubiquitinated when over-
expressed in cells. Whether Nedd4.2 is important for this ubiquitination, and if there is a 
physiological relevance of this ubiquitination in the context of infection, is unexplored. 
Clearly, Nedd4.2 within the cell is important for efficient Ad infection. These studies will 
hopefully provide more evidence for its role during the entry process. 
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Host protein interactions with pVI 
Pull down experiments performed here suggest that purified pVI interacts with 
multiple host proteins, but does not clarify whether these are direct interactions or via 
pVI interacting with protein complexes. Additionally, these are likely interactions that 
occur with non-ubiquitinated pVI, as the purified protein is incubated with cell lysates, 
however the ubiquitination status was not tested. It is unlikely that Nedd4.2 proteins have 
ubiquitination activity in the absence of excess ubiquitin and ATP, and at the low 
incubation temperatures. The current conditions can be altered to assess whether the pVI 
ubiquitination status changes the profile of pVI-host protein interactions. Incubating 
lysates with pVI at physiological temperature in the presence or absence of ATP and 
purified ubiquitin would allow endogenous Nedd4.2 potentially interacting with pVI to 
ubiquitinate pVI. The ubiquitination status of pVI would be assessed by immunoblotting 
for pVI, and we would anticipate multiple pVI-positive bands if ubiquitination is 
occurring. If pVI ubiquitination affects viral-host protein interactions, then we would 
expect to see a distinct banding pattern in lysates containing ATP and excess ubiquitin. 
GFP-lysate samples, as well as ATP- and ubiquitin-free controls would shed light on any 
differences observed in the pull down assays. 
Furthermore, we could not specify which interactions during the pull down assays 
are pVI-PPxY-specific, as we were unable to purify pVI-M1 protein from bacterial 
lysates, likely due to its lytic activity. Instead of attempting to purify full-length mature 
pVI, future studies could alternatively perform these studies using pVI lacking the 
membrane lytic domain. These studies would purify truncated pVI-WT and pVI-M1 and 
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perform pull down assays, using mature pVI-WT and GFP proteins as positive and 
negative controls, respectively. This could also potentially yield cleaner pull downs, as it 
should not pull out anything bound by the lytic -helical domain. We would expect that 
truncated pVI-M1 would not pull down one or more of the proteins pulled down by pVI-
WT. These could then be sent off for identification, and focus attention on the relevant 
interaction. 
Microtubules 
Contributions of microtubule motors in aiding viral escape 
Microtubules (MTs) are the major network through which many host molecules 
traffic throughout the cell. Its maintenance is absolutely essential for cell movement, 
division, and survival. Thus, it is not surprising that many pathogens take advantage of 
the MT network to mobilize to their target destination. We find here that Ads require both 
MT motors dynein and kinesin for efficient infection, and both are involved in efficient 
virion penetration into the cytosol. 
Dynein 
A myriad of previous studies focus on the contributions of dynein to adenovirus 
cell entry. Inhibiting dynein via siRNA knock downs and protein overexpression have 
clearly implicated its role in entry and proper viral targeting to the nucleus, but these 
types of assays have severe pleiotropic effects on global cell function and growth. 
Additionally, the specific point in entry that the virus recruits and interacts with dynein in 
these assays has not been fully characterized. We utilized a recently developed small 
molecule inhibitor of the dynein motor function, called ciliobrevin D (CilioD) to 
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specifically ask at what stage in entry does Ad initially recruit dynein, and what the 
contributions of the pVI-PPxY motif are in virus-dynein interactions. Using this small 
molecule inhibitor allowed us to immediately probe the role of dynein in Ad entry (i.e., 
over the course of hours) without drastically affecting the motor’s function over a long 
period of time (i.e., days), as is the case with siRNA or overexpression models. 
We found that treating cells with CilioD restricts Ad5-WT infectivity 60%, which 
corresponds to increased colocalization with gal3-positive endosomes during entry 
(Figure 10). Previous dynein inhibition studies suggest that dynein-virus interactions 
occur after the virus penetrates into the cytosol, and so to our knowledge these are the 
first data to implicate a defect in viral escape in the absence of efficient dynein motor 
activity. We further found that Ad5-M1 infectivity is partially restored upon inhibiting 
dynein (Figure 10). In fact, when transduced with the same physical number of particles 
per cell, Ad5-WT and Ad5-M1 specific infectivities were similar when treated with 
100μM of the inhibitor (data not shown). These results imply that the defect in Ad5-WT 
observed upon inhibiting dynein is absolutely dependent on the pVI-PPxY motif. The 
partial restoration we observe during Ad5-M1 transduction is likely to an inability to 
lysosomes and/or autophagosomes to properly mobilize and fuse together, since other 
data indicate that lysosome transport throughout the cell requires dynein function. 
The next logical step to assess in this model is determining how Ad capsid 
specifically exploits dynein after membrane rupture. Published data suggest that the 
major capsid protein hexon interacts with dynein to mediate transport to the nucleus [290, 
388]. These authors show that pH-primed hexon (pH 4.4) interacts with dynein in vitro, 
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and that this interaction is dependent on the hypervariable region 1 (HVR1) sequence in 
hexon. Our lab previously generated an Ad mutant that replaced the hexon HVR1 with an 
epitope from the Plasmodium falciparum protein, Pfs25 (Ad5-HVR1D3). This 
replacement removes the putative HVR1 sequence responsible for dynein interactions. 
We found that Ad5-HVR1D3 has a modest ~2-fold defect in infectivity, so with 
the data from the other reports in mind, it stood to reason that this virus’ defect is due to 
an inability to interact with dynein. To test this, CilioD- or DMSO-treated cells were 
transduced with Ad5-WT and Ad5-HVR1D3, and relative changes in infectivity were 
assessed. We predicted that if the Ad5-HVR1D3 defect is due to an inability to interact 
with dynein, then cells transduced with Ad5-HVR1D3 in the presence of CilioD should 
have no difference in infectivity compared to DMSO controls, or perhaps a partial 
increase in activity similar to that observed with Ad5-M1. However, we found that 
treating cells with CilioD restricted the Ad5-HVR1D3 virus’ relative infectivity just as 
much as Ad5-WT-transduced cells (Figure 21). These results indicate that, in our hands, 
hexon HVR1 is dispensable for Ad5 utilization of dynein. Additionally, as its name 
suggests, Ad5 HVR1 is hypervariable and is not conserved among other Ad species. 
Thus, it is difficult to believe that a poorly conserved protein sequence from a single Ad 
species is responsible for the virion’s critical interaction with dynein. 
The results from the Vallee lab with pH-primed hexon are also difficult to resolve 
in our infection model, as we find that virus ruptures membranes much earlier in the 
endocytic cycle than the necessary drop in endosomal pH to prime hexon would occur. 
However, they do show that expressing hexon in HeLa cells 48 hours prior to viral 
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Figure 21: Contributions of hexon HVR1 in dynein interactions. HeLa cells were 
transduced with the indicated virus in the presence or absence of 50μM CilioD. GFP-
positive cells were assessed by flow cytometry. Infectivities are normalized relative to 
DMSO vehicle controls. 
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infection restricts Ad accumulation at the nucleus one hour post-entry [290], indirectly 
indicating a role for hexon in viral transport. Interestingly, they also point out that hexon 
overexpression disorganizes microtubules at the periphery, but do not explore this 
further. Taking into consideration our DLC1 siRNA (Figure 9) and Ciliobrevin D (Figure 
10) results in conjunction with the Ad5-HVR1D3 data, these observations would indicate 
that, while dynein is clearly important in Ad entry, virion interactions do not occur 
through DLC1 or Ad5 hexon HVR1. 
These results suggest a complex interplay in viral capsid proteins during transport. 
Our Ad5-M1 data plainly demonstrate that the pVI-PPxY motif is a critical component in 
viral exploitation of dynein for endosomal egress, but do not specify whether dynein-
virus interactions downstream of egress occur, and if so certainly do not indicate what 
proteins are involved in such an interaction. It is possible that, although hexon likely does 
not interact with dynein in a pH-dependent manner, it still has the capacity to interact 
with some subunit of dynein in the context of virus entry after partial disassembly, once 
the virion egresses from the endosome into the cytosol. Other capsid proteins that are 
associated with the penetrating virion prior to genome delivery (proteins V, VII, and X) 
do not interact with the dynein 74.1 kDa intermediate chain or the dynactin component 
p150Glued, and do not affect viral targeting to the nucleus during entry, suggesting they are 
not involved in microtubule-mediated viral transport [290]. Fiber, penton base, pIX, 
pIIIa, and pVIII were not assessed, as they were presumed lost upon uncoating. It is 
important to fully characterize which viral proteins interact with dynein in vivo during 
infection, and at the discrete steps of entry these interactions occur, and designing tightly 
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controlled experiments will help to elucidate these steps. Using small molecule inhibitors 
such as ciliobrevin D to regulate dynein function on a small time scale with putative 
dynein-interacting Ad mutants will further aid in delineating the mechanisms of dynein 
recruitment both upon endosomal rupture and after viral penetration into the cytosol. 
Kinesin 
Kinesin function, while also implicated in Ad entry, has not been studied in as 
much detail as dynein interactions. Although bi-directional movement is observed in live 
cell imaging of Ad during entry, microinjecting antibodies against kinesins has no effect 
on virion accumulation at the nucleus [289]. This, in combination with data suggesting 
that fewer kinesin molecules interact with the capsid compared to dynein [389] likely led 
to the assumption that kinesin is dispensable for efficient virus infection. However, a 
recent publication indicated that cells knocked down for KLC1 were defective for Ad 
genome delivery compared to control cells [291]. Their data suggest that pIX interacts 
with kinesin and the NPC at the nuclear membrane to mediate NPC disruption and 
genome delivery into the nucleus. However, although pIX interacts with KLC1 in in vitro 
pull down assays, we found that knocking down KLC1 similarly restricts both Ad5-WT 
and Ad5-ΔpIX viral infectivities (Figure 19). These data, along with our other results, 
indicate to us that a) kinesin knock down inhibits Ad infection independently of pIX 
present on the capsid, and b) the defect in Ad5-ΔpIX lies in endosomal egress 
downstream of evading autophagy. However, how kinesin affects virus infection still 
remains a valid question. 
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Since pIX is not involved in kinesin-facilitated viral infection, this suggests some 
other capsid protein is involved. During their initial assessments, Strunze, et al. found 
that pIIIa and small quantities of fiber are also pulled down by KLC1 TPR after heat-
dissociating virions [291]. They dismissed these as putative kinesin interactors since they 
are quickly shed from the capsid during entry. However, it may be wise to assess these 
capsid proteins for kinesin interactions in immunoprecipitation assays, and further 
determine kinesin-binding residues if they do interact. Repeating these infectivity studies 
with mutant viruses that do not interact with kinesin via these proteins might allow us to 
determine how kinesin aids viral infection. 
Further attempts to assess the defect in Ad entry caused by kinesin knock down 
suggested are preliminary. We found that, although Ad5-WT is internalized and ruptures 
endosomes equally efficiently in both control and KLC1 siRNA cells, there are fewer 
virions associated with gal3-positive endosomes at 30 minutes in kinesin knock down 
cells when compared to control (Figure 19). Furthermore, knocking down kinesin does 
not appear to affect Ad5-WT accumulation at the nucleus, corroborating previously 
published reports (data not shown). How kinesin apparently impedes early viral 
endosomal escape but facilitates efficient infection requires further investigation. The 
report from the Greber lab suggests that knocking down kinesin prevents proper 
uncoating of the virus at 3hpi. Taken together, these results may indicate that, although 
virus enters into the cytoplasm faster in the absence of kinesin, relevant proteins within 
the viral capsid are not in the proper conformation due to inadequate uncoating. Perhaps a 
mechanical “tug-of-war” on the capsid between kinesin and another protein (such as 
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dynein or membrane fragment-bound receptors) facilitate appropriate capsid dismantling 
prior to endosomal egress. Testing this would first require determining the capsid 
proteins that physiologically interact with kinesin during entry, and further defining the 
precise sequences that specifically interact with the motor. Once these sequences are 
known, Ad5 mutants could be generated that contain a scrambled sequence that does not 
bind to kinesin. If kinesin-protein interactions facilitate virus uncoating, then fewer 
virions would disassemble in cells transduced with the mutant virus compared to WT. We 
would expect that the mutant would also egress from endosomes with kinetics similar to 
what we observed in KLC1 siRNA cells. 
When it is not transporting molecules throughout the cell, the kinesin-1 complex 
tail folds in on the motor head and exists in an autoinhibited conformation [390]. In 
Drosophila, binding synthetic cargo releases kinesin from this state, allowing transport 
on microtubules [390]. However, research utilizing mammalian kinesin-1 suggest that 
binding native cargo alone may not sufficiently relieve kinesin from autoinhibition [391]. 
More recently, it was found that the RAN-binding protein 2 (RANBP2) is an allosteric 
activator of kinesin-1 [109]. RANBP2, also known as Nup358, is a major nucleoporin 
found at the NPC, and previous data indicate that although Nup358 knockdown does not 
restrict Ad targeting to the nucleus, it inhibits Ad uncoating similar to the observations 
found with KLC1 siRNA cells [291, 392]. It would be interesting to assess whether 
knocking down both KLC1 and Nup358 further restricts viral infection compared to 
individual knock downs. Perhaps Nup358 must activate virion-associated kinesin to both 
facilitate proper uncoating and simultaneously give the virus the opportunity to egress 
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from ruptured endosomes. A previously published model postulates that this event also 
supports genome delivery, but this hypothesis was not tested in either their hands or ours 
[291]. Since many studies suggest that genome delivery occurs with membrane-free 
virions, we hypothesize that virus egressing from lysed, nuclear-targeted endosomes must 
traffic back to the nucleus at a later time to deliver their genome. If this is the case, it 
would be important to further determine whether capsid dissociation occurs upon viral 
penetration into the cytoplasm or after viral relocalization to the NPC. 
Protein IX function in Ad entry 
To understand the intricacies of Ad infection, it is important to define the 
contributions of the protein components of the viral capsid in terms of their interactions 
with the host. In revealing these interactions, we will further delineate potential 
influences of the capsid proteins both in aiding viral entry and their effects in evading 
detection or restriction. In this study, we focus on the contributions of a so-called minor 
capsid protein, pIX, during entry. Until recently, capsid-associated pIX was thought to 
only act as a capsid stability protein, as assessed by increased capsid thermolability in 
virions deleted for the protein. A recent publication implicates pIX involvement in 
interacting with kinesin, but we show here that kinesin’s contributions to Ad infection are 
independent of the presence of pIX. Moreover, we show that Ad5-ΔpIX’s defect in 
infectivity is a result of an inability of virions to properly penetrate into the cytosol. 
To further characterize pIX’s activity during viral entry, we attempted to assess 
the contributions of individual domains of the protein. The protein consists of three 
putative domains: an N-terminal domain (NTD), a C-terminal domain (CTD), and an 
  
124 
alanine-rich linker [205]. The NTD is critical for incorporation into the viral capsid, and 
embeds into hexon trimer interfaces within each facet of the capsid [305]. Immunogold 
labeling reveals that the NTD in mature capsids is not detectable by antibodies [393]. 
Conversely, the CTD is not required for incorporation, but is recognized by antibodies in 
both intact and disrupted virions, suggesting it is exposed to the cytoplasm during entry. 
Thus, we expected to find that the pIX CTD is critical in assisting viral infection. To test 
this, we stably expressed either HA-tagged full-length pIX (HA-pIX-FL) or protein that 
is truncated for its CTD (HA-pIXΔCTD) in HeLa cells. When we transduced Ad5-WT or 
Ad5-ΔpIX, we observed enhanced infectivities of both viruses in HA-pIX-FL compared 
to control cells (Figure 18). 
This result surprised us, since we expected that soluble HA-pIX in the cells would 
act as a competitive inhibitor to restrict WT infectivity. However, previous reports show 
that pIX expression in cells either through viral transduction or transfection produces 
pIX-positive inclusion bodies in host cell nuclei [305, 309]. These inclusion bodies 
sequester promyelocytic leukemia protein (PML), and during normal viral replication this 
event is important for optimal virion production. Nonetheless, even if the majority of 
HA-pIX is found within the nucleus, some protein should be present in the cytoplasm to 
compete with Ad5-WT for pIX-interacting partners during transduction. Perhaps pIX 
stably expressed in cells constitutively sequesters PML bodies, significantly enhancing 
virus infection greater than what is accounted for in the Ad5-ΔpIX virus’ defect. 
However these data do not exclude the possibility that pIX-host interactions are important 
for efficient Ad escape from endosomes during entry. To separate these functions, it may 
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be possible to design a pIX mutant that does not import into the nucleus. This way, pIX 
should remain in the cytoplasm to interact with host proteins, but cannot inhibit PML 
activity. We would then anticipate a restriction in Ad5-WT infectivity in cells expressing 
the pIX mutant compared to control cells. Further, there should be no change in Ad5-
ΔpIX infectivity. 
IFA studies assessing Ad5-WT colocalization with gal3 in HA-pIX stable cells 
may also provide insight into whether HA-pIX actually acts as a dominant negative for 
Ad endosomal escape. If it has dominant negative activity, we would expect to see more 
Ad5-WT colocalize with gal3 compared to controls. The results from the IFA 
experiments, together with the transduction assay data, could distinguish two distinct 
roles pIX has during adenovirus entry: one in properly targeting virions to NPCs, and 
another in inhibiting PML body activity at the early stages of replication. Interestingly, 
transducing cells stably expressing HA- pIXΔCTD yields a slight, but significant, 
increase in both virus’ infectivity. Previous literature indicates that the C-terminal coiled-
coil domain is important for pIX trans-activating and PML sequestering activity. Our data 
indicate that while this likely is predominantly the case, the N-terminal or linker domains 
of pIX may play a part in facilitating Ad infectivity. Again, ongoing IFA studies will help 
to elucidate which of these domains are important for mediating virus escape from 
endosomes during entry. 
How stably expressing pIX in cells enhances infection is unclear. A confounding 
observation in a previous study shows infection with Ad5-ΔpIX does not disrupt NPCs as 
well as WT Ad, as assessed by 40kDa dextran-FITC infiltration [291]. Although capsid-
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associated pIX is important for NPC disruption, it is not known whether pIX plays a 
direct role in the event. Similar to these observations, NPC disruption is also prevented in 
WT infections when KLC1 or Nup358 are knocked down by siRNA [291]. These data 
explicitly implicate a role for all of these molecules at the NPC, but how they are 
involved with each other is still not understood. We find that KLC1 knock down restricts 
Ad5-ΔpIX virus as effectively as Ad5-WT, suggesting that these defects are distinct from 
each other. Whether the deficiencies in infection observed with KLC1 and Nup358 knock 
downs are part of the same event has not been assessed.  
Although virus deleted for pIX more or less properly traffics to the perinuclear 
area, it does not colocalize with Nup358/Nup214 NPC complexes as efficiently as WT. 
Strunze, et al. do show that pIX-deleted virus still interacts with the KLC1 TPR, just not 
to the extent observed with WT virus [291]. The little amount of kinesin still present may 
be enough for the motor to enact its function during infection. This could explain why 
knocking down KLC1 inhibits both Ad5-WT and Ad5-ΔpIX virus, and these results may 
suggest that the mutant virus’ failure to disrupt the integrity of the NPC is simply due to 
an incapacity to accurately target to NPCs. If Nup358 is important to activate kinesin 
associated on the viral capsid as described above, then this would also explain why Ad5-
ΔpIX is retained in endosomes at the nuclear membrane. This could be tested by 
assessing WT colocalization with gal3 in Nup358 knock down cells. If viral targeting to 
Nup358 is important for viral egress, then WT virus will be retained in gal3-positive 
endosomes at the nucleus in knock down cells compared to control cells. 
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Taking all of our data together, we hypothesize a two-step model of viral 
accumulation at the nucleus (Figure 22). After membrane rupture at or near the cell 
surface, gal8 is recruited by lumenal N-linked glycans to alert the host to danger. 
Autophagy machinery is quickly recruited to sites of injury, as evidenced by our 
observations showing that both gal3 and LC3 puncta are induced and colocalize with 
virus within 30 minutes of virus internalization [324]. LC3 cleavage and aggregation at 
sites of damage during Ad infection is dependent on TBK1 activity (Figure 4), suggesting 
a role for the kinase in autophagosome nucleation and/or expansion. Simultaneously, the 
ruptured endosome recruits microtubules and their associated proteins via the PPxY motif 
within protein VI. Multiple results demonstrate that pVI-M1 is defective for microtubule 
associations: transient transfections of pVI-M1 do not colocalize with microtubules as 
well as pVI-WT, live cell imaging suggests that pVI-WT traverses the cytoplasm 
bidirectionally and with high velocities whereas pVI-M1 does not do so as efficiently 
[209], and treating cells with nocodazole to depolymerize microtubules does not restrict 
Ad5-M1 infectivity as severely as Ad5-WT [324]. 
Our ciliobrevin D results indicate that after microtubules are recruited, dynein 
interacts with membrane fragment-associated virus and transports it towards the nucleus, 
since virions in CilioD-treated cells are confined within gal3-positive endosomes at the 
cell periphery (Figure 10). Whether the virus takes advantage of dynein to evade 
autophagy machinery remains unclear, since autophagosome formation and lysosomal 
targeting also require dynein. The PPxY motif likely targets virus confined within 
endosomes away from sites of expanding, but incomplete, autophagosomes to mediate  
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Figure 22:  Two-step model of adenovirus entry. (1) Adenovirus interacts with primary 
(CAR) and secondary (v integrin) cell surface receptors, inducing virion uptake via 
clathrin-mediated endocytosis. (2) Mechanical perturbations between the receptors and 
virus partially dissociate the capsid, revealing pVI. Freed pVI intercalates into the lipid 
bilayer and ruptures the endocytic membrane at or very near the cell surface, recruiting 
galectins to initiate the host danger response and activate autophagy machinery. (3) 
Endosome-associated virus engages microtubules via dynein, translocating to perinuclear 
locations. Virus egresses from endosome fragments towards the cell periphery by 
unknown mechanisms, where (4) it again interacts with microtubules to target to NPCs. 
(5) Opposing forces between virus, microtubule motors, and nucleoporins disrupts the 
NPC and the viral capsid, importing the viral genome into the nucleus to initiate 
replication and the generation of progeny virions. 
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virion evasion of lysosomal degradation. Regardless, dynein is necessary to mobilize 
virus-endosome complexes to the perinuclear area. Additionally, our IFA data in KLC1 
knock down cells imply that KLC1 interactions may be important to retain virus within 
endosomes during cytosolic transport, potentially until the capsid reaches an area where it 
can properly uncoat (Figure 19). 
Once virus is perinuclear, our live cell imaging assays show that the virus 
egresses from gal3-positive endosomes towards the cell periphery. Three observations 
suggest that virus escaping from endosomes at the nucleus is likely not delivering its 
genome into the nucleus. First, previous reports indicate that virus targeting to NPCs are 
free of endosomal membranes [291, 394, 395]. Second, we show here the Ad5-ΔpIX is 
retained in perinuclear gal3-positive vesicles (Figure 17), and third, Strunze, et al. report 
that Ad5-ΔpIX is not targeted to NPCs on the nuclear membrane [291]. Taken together, 
these data suggest that virus penetrates into the cytosol at the nuclear periphery, and 
moves towards the cell periphery. The membrane-free virus must then traffic back to the 
nucleus and target to Nup358/Nup214-positive NPCs to deliver its genome. Others 
suggest that dynein interacts with the HVR1 region of hexon to traffic naked virus toward 
the nucleus so the capsid can dock at the NPC [290, 340, 396]. However, as described 
earlier in this text they suggest that hexon requires priming by pH 4.4 to facilitate such an 
interaction, and we and others previously showed that Ad5 ruptures endosomes well 
before they achieve a pH that low. As such, it is unclear how the virus mediates transport 
back to the nucleus to dock at the NPC. Regardless, once at the NPC, dynein becomes 
anchored to Nup214, and kinesin interacts with nup358 and capsid. Opposing motor 
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functions between dynein and kinesin disrupt the NPC and fully uncoat the capsid, 
revealing the viral genome and facilitating its delivery into the nucleus [291]. 
Contributions of other factors during Ad Infection 
 There are other factors, both viral and host, not focused on in this study that are 
important during infection. How these varied components influence each other to affect 
viral entry require broader study. Recent studies on some of these factors may shed light 
on such influences. 
Calcium influx 
 A very recent report shows that Ad-induced membrane damage at the plasma 
membrane mediates calcium influx into cells [397]. The study suggest that increases in 
calcium concentrations in the cell facilitate lysosomal exocytosis, increasing ceramide 
concentrations at the plasma membrane. In turn, this activity leads to increased 
endocytosis of membrane lesions, which expedites viral uptake. Additionally, other 
reports indicate that mitochondria traffic to area with high concentrations of calcium in 
neurons via dynein- and kinesin-dependent transport [398, 399]. Once present at these 
sites, the high calcium concentrations arrest kinesin motor activity, which is only relieved 
once calcium levels drop. Perhaps calcium influx directs dynein and kinesin to points of 
viral endocytosis, where the motor proteins can interact with the virion immediately upon 
vesicle rupture to facilitate the evasion of autophagy machinery. In this model, kinesin 
activity is hindered until the virus traffics away from sites of autophagosomal formation, 
allowing dynein motor function to dominate. This model would implicate a mechanism 
of microtubule motor recruitment to Ad-containing endosomes. 
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Adenoviral protease 
The adenoviral protease (AVP) has a very well characterized role in viral 
replication during the capsid maturation process, whereby cleaving viral preproteins 
within the formed capsid puts the virion in a metastable conformation to facilitate 
disassembly upon infecting a new host cell [189]. The mature Ad5 virion contains 11 
copies of AVP [191], however due to its essential function in replication, its importance 
during entry is difficult to characterize. Chemical inhibition of the protease via reduction 
and alkylation/oxidation of virions prior to transduction severely inhibits viral infection 
by approximately 80% at the disassembly stage, after virus targets to NPCs [191]. 
Although the protease is the major apparent target of NEM-mediated alkylation, penton 
base, fiber, pV, and two unidentified proteins are also alkylated in their inactivation 
procedure. Thus, the contributions of AVP in viral entry relative to these other proteins is 
not entirely clear. Interestingly, pVI degradation is inhibited in NEM-alkylated virus 
preparations, yet pVI itself contains no cysteine residues for NEM to alkylate. Although 
membrane rupture is not apparently affected upon alkylation, whether another alkylated 
viral protein contributes to pVI function during viral entry, and at what step this may 
occur requires further testing. Subsequent publications suggested that E1A inhibits nitric 
oxide synthase, and nitric oxide itself restricts protease activity in vitro [400, 401]. 
 We attempted to assess the explicit contributions of AVP during entry using 
newly developed AVP inhibitors, 37248 and 37249 [402]. These inhibitors restrict AVP 
cleavage function 9- (37248) and 35-fold (37249) in vitro, but were not tested in cell 
culture conditions. We tested the effect of these inhibitors on Ad5-luc infectivity, with 
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VSVg-luc as a control for inhibitor activity. Although we found these inhibitors restrict 
luc production in cells transduced with Ad5-luc, they also similarly restrict VSVg-luc 
infectivity (data not shown). These results suggest to us that, in addition to their effects 
on AVP, these inhibitors also affect the activity of one or more host factors. Greber, et al. 
showed that AVP alkylation only occurs after the virion is treated with the reducing agent 
DTT, suggesting that the chemical can only access the protease upon reduction of the 
virion. More intricate studies that specifically target the AVP without affecting other viral 
or host protein activities need to be designed to precisely elucidate its specific 
contributions. 
Host-mediated viral ubiquitination 
 Although Nedd4.2 mediates pVI ubiquitination in in vitro assays, the 
physiological effects of this remain untested. Furthermore, it is not known whether other 
Ad5 capsid components are ubiquitinated during entry. Pathogen ubiquitination is a 
critical step in targeting intracellular bacteria for autophagy, implying that a similar 
process could occur during Ad entry. Determining the proteins that are ubiquitinated after 
membrane rupture would aid in determining what components of the capsid and/or host 
mediate the targeting of autophagy machinery to sites of endosomal damage. 
Furthermore, it would potentially provide additional targets to assess for infectivity 
defects during entry. 
 Leucine-rich repeat and sterile alpha containing motif 1 (LRSAM1) and Parkin 
are E3 ubiquitin ligases recently described to respectively ubiquitinate Salmonella 
typhimurium and Mycobacterium tuberculosis organisms upon membrane rupture  [74, 
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403]. In the case of Salmonella infection, LRSAM1 did not fully inhibit pathogen 
ubiquitination, implicating other unidentified ubiquitin ligases are also involved. These 
data imply that Nedd4.2 may not be the only ubiquitin ligase involved in Ad infection. 
Identifying if this is the case, and further teasing out the contributions of each ligase 
during different pathogen infections, may aid in our understanding of the differential 
regulation in autophagy targeting by the host. Both LRSAM1 and pIX contain leucine-
rich repeat (LRR) domains, which are thought to act as protein recognition motifs [305, 
404, 405]. Whether the LRR domain of either protein is important for protein interactions 
during Ad entry is unknown. Interestingly, observations suggest that LRSAM1 may 
stabilize NDP52 associations on ubiquitinated pathogens [74]. Whether such stabilization 
is required to target autophagy machinery, or if it is only explicitly important during 
Salmonella infections, is unknown. Assessing whether NDP52 still targets to Ad-ruptured 
endosomes in cells knocked down for LRSAM1 would be a first step in determining the 
role of LRSAM1 in autophagy.  
 Previous reports show that AVP contains deubiquitinating (DUB) activity late in 
infection between 24 and 36 hpi [192]. DUB activity is enriched in acid soluble nuclear 
fractions, and specifically deubiquitinates mono- and di-ubiquitinated histone H2A. No 
studies have assessed whether AVP has global DUB activity at early times during 
replication, but others found that Ad does not appear to induce global ubiquitination of 
host or viral proteins as detected by western blot ([406], personal communication from 
Harald Wodrich). More specifically, no data establish whether AVP enacts local DUB 
activity during entry. It would be interesting to assess whether AVP DUB activity is 
  
134 
important for viral entry, but as stated above it is difficult to manipulate AVP activity in 
entry without affecting its essential functions in replication. If possible, separating the 
AVP deubiquitinating activity from its viral proteolysis function may aid in assessing 
whether it plays a role in viral entry. 
Consequences of microtubule post-translational modifications during Ad entry 
 Although MTs have such a significant role in cell function and viral manipulation, 
there is still a vast gap in our knowledge in how MTs specifically interact with and 
transport cargo. We are only just beginning to understand how MT PTMs affect cargo 
specificity and protein interactions, but many studies are still necessary to fully 
comprehend the contributions of individual PTMs. Ads require MTs for transport within 
the cell and ultimately to the nucleus, to deliver their viral genome. Others previously 
showed that MT stabilization with paclitaxel during Ad transduction enhances the nuclear 
accumulation of virions [407]. Furthermore, Ad transduction enhances MT stabilization 
via PTMs within one hour post-entry [408]. This report also notes that Ad infection 
enhances MT growth after nocodazole washout, compared to mock infected cells. MT 
stabilization in Ad infections is much faster compared to other viral infections, and 
occurs via increased acetylation and detyrosination of tubulin, shifting the balance of MT 
dynamics towards a state of net growth. Ad mediates MT PTMs by the Rho GTPases 
RhoA and Rac1. Whether microtubule stabilization via acetylation specifically enhances 
Ad transport, or is necessary to recruit particular MAPs is not known.  
The eukaryotic deacetylase HDAC6 is implicated in deacetylating tubulin; 
overexpression of HDAC6 induces a global decrease in acetylated -tubulin, whereas 
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HDAC6 depletion increases acetylated -tubulin pools. Perhaps HDAC6 expression 
could be utilized to assess the effects of tubulin acetylation on Ad entry. Ad localization 
in cells either overexpressing or knocked down for HDAC6 could be assessed by IFA. If 
MT acetylation is important for proper Ad targeting, then overexpressing HDAC6 should 
restrict Ad accumulation at the nucleus, and HDAC6 depletion may enhance virion 
transport to the perinuclear area. If this is the case, further assessments to determine 
whether virus still escapes endosomes in the absence of MT acetylation can be 
performed. Although reports using Ad to probe microtubule PTMs are sparse, researchers 
are now beginning to focus efforts on this area of investigation. Studies using Ad will 
allow researchers to flesh out the molecules involved in MT PTMs during viral infection, 
and global effects enacted on the host cell under these conditions. 
Intermediate filaments 
 In addition to microtubules, the cell’s cytoskeleton is also composed of actin and 
intermediate filaments (IFs). Actin is required for initial Ad virion endocytosis, and actin 
translation is later shut down during replication [251, 409]. Compared to microtubules 
and actin, however, the function of IFs during Ad entry are not well characterized. 
Cytokeratin 18, an IF found in epithelial cells, is cleaved by AVP late in infection, 
contributing to cytopathic effect (CPE) and viral release [410, 411], however its integrity 
is maintained normally during Ad entry. Conversely, another IF called vimentin is 
quickly depolymerized by the host during entry – within five minutes – but has no effect 
on CPE [412]. Vimentin is important both in cell integrity and in securing the positions of 
various organelles within the cell, including the nucleus, ER, and mitochondria [413, 
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414]. Moreover, Ad interacts with both tubulin and vimentin 30 minutes after infection 
[415], suggesting that vimentin may have some function during Ad entry. Unfortunately, 
this role is unclear as further studies of vimentin using Ad were not pursued. 
Nevertheless, vimentin studies in other viral infection models implicates its necessity 
during infection. 
Both parvovirus and foot-and-mouth disease virus replication requires a 
functioning, intact vimentin structure in host cells [63, 416]. Furthermore, studies using 
African swine fever virus show viral factories in infected cells require the formation of a 
vimentin “cage” around them for optimal replication [417]. In this model, vimentin is 
phosphorylated by CaM kinase II, but it is unknown whether this phosphorylation event 
is required for the caging phenomenon. Notably, beclin-1 interactions with vimentin via 
regulatory 14-3-3 proteins inhibits autophagosome formation [418]. Perhaps vimentin is 
processed during Ad infection to enhance the activation of autophagy. We attempted to 
assess whether acrylamide-inhibition of vimentin affects Ad infectivity, but results were 
inconsistent and not pursued further (data not shown). Still, it could prove useful for 
future studies to assess if vimentin interactions with the viral capsid has a functional role 
during Ad entry. Uncovering such contributions, if any, as well as determining which 
capsid proteins enable vimentin binding may provide insight as to how Ad might exploit 
the IF arm of the cytoskeleton. 
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Adenovirus Mutants as Potential Vaccine Vectors 
Introducing mutations into less seroprevalent Ad species 
 As stated earlier, Ads are useful base vectors for designing vaccine platforms. 
Using the various defects of the mutants we have studied, we can further specifically 
target these vaccine vectors to various locations within the cell for their designated 
function. For example, we can utilize the Ad5-M1 mutant for vectors that contain 
pathogen epitopes on the viral capsid to enhance their delivery to lysosomes. Lysosomal 
targeting degrades the virus, and increases epitope loading onto MHC class II for CD4+ T 
cell recognition. Although we utilize Ad serotype 5 for our studies in cell culture, it is not 
an optimal candidate for Ad vaccine vectors due to very high levels of preexisting 
immunity worldwide [419]. Previous studies suggest that neutralizing antibodies against 
Ad mainly target the hypervariable region of hexon [420], and current research is aimed 
at replacing these regions in recombinant Ad5 backbone vectors to circumvent immunity 
[421, 422]. While early tests are promising, concurrent studies utilizing other, less 
seroprevalent Ads may also prove fruitful. 
Ad12, a subgroup A virus, is one of the more phylogenetically distinct human 
Ads compared to Ad5 [423, 424]. Replacing the Ad5 hexon HVR with Ad12’s sequence 
produces a viable chimeric virus capable of bypassing Ad5 preexisting immunity in mice. 
We compared the seroprevalence of neutralizing antibodies against Ad12 and Ad5, and 
found that Ad12 seroprevalence in local cord blood samples is significantly lower 
compared to Ad5 (Figure 23). Nine of the fifteen samples (60%) inhibit Ad5 infectivity 
by greater than 50%, and eight are restricted by more than 75% (53% of samples). 
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Conversely, only 6 cord blood samples (40%) inhibit Ad12 infectivity by 50%, and only 
2 (13%) restrict Ad12 more than 75%. Furthermore, Ad12 infectivity is 100-200-fold 
defective compared to Ad5 in culture, and Ad12-infected dendritic cells induce CD4+ T 
cells to secrete more IFNγ compared to Ad5-WT, and at similar levels compared to Ad5-
M1 (Figure 24). Since both Ad5 and Ad12 pVI contain a conserved PPxY motif, it would 
be interesting to assess whether introducing the M1 mutation into Ad12 would further 
enhance antigen presentation and CD4+ T cell-mediated immune responses. These 
studies, along with additional research using Ad12 and other rare Ad serotypes, could 
prove fruitful in attempting to develop more targeted Ad-based vaccine vectors. 
Conclusions 
Overall, in this study we identify the mechanism of host sequestration of Ad-
mediated damaged endosomes through autophagy occurs via TBK1 activity. TBK1 
facilitates LC3 cleavage, likely to expedite autophagosome formation. Although the 
signaling cascade to induce autophagy was not ascertained, we eliminated some potential 
pathways mediated through ROS signaling. We also explicitly determined the 
contributions of dynein in Ad evasion of autophagy. Chemical inhibition of dynein motor 
function restricts Ad absconding from ruptured endosomes and reduces nuclear targeting 
of virions. Furthermore, we revisited previous reports implicating that kinesin recruitment 
to Ad capsids is mediated by pIX. We found that kinesin depletion restricts virus 
infectivity in a pIX-independent manner, contradicting the previous findings. More 
detailed studies to assess the defect suggest that kinesin knock down enhances viral 
egress at very early times. Data from other labs indicates that virions in cells knocked 
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down for kinesin do not efficiently uncoat, suggesting a role for kinesin during 
endosomal egress properly primes the virion to properly dissociate and deliver its viral 
genome. Future studies will specifically determine the viral proteins interacting with 
kinesin, and how such interactions facilitate uncoating. 
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Figure 23: Ad12 pre-existing immunity. HeLa cells were incubated with cord blood 
diluted with DMEM to 1:16 its concentration and transduced with Ad5gfp or Ad12. Ad12 
samples were stained with rabbit anti-Ad12 antisera and 488-conjugated goat anti-rabbit 
secondary antibody. Cells were imaged and quantified by hand using ImageJ software A. 
Representative images of cells transduced with Ad5gfp or Ad12 in the presence of cord 
blood or DMEM alone. B. Effects of 15 different cord blood samples on Ad5 and Ad12 
infectivity. Percent infections are normalized to DMEM only sham infections, 
standardized to 100%. Pre-existing immunity was determined as inhibiting infection by 
greater than 50% relative to controls. 
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Figure 24: CD4+ T cell activation by Ad vectors. A. Splenocytes from Ad5-infected 
mice were stimulated ex vivo with replication-defective Ad5 or UV-inactivated Ad12. 
IFNγ-producing cells determined by ELISPOT. B. Human monocyte-derived DCs were 
infected with the indicated virus for 2 hours. Cells were washed and incubated with an 
equivalent number human CD4+ T cell clones recognizing a conserved peptide in hexon 
(amino acids 910-924 in Ad5) for 24 hours. Supernatants were analyzed for IFNγ by 
ELISA. 
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